<SEC-DOCUMENT>0000885725-21-000002.txt : 20210112
<SEC-HEADER>0000885725-21-000002.hdr.sgml : 20210112
<ACCEPTANCE-DATETIME>20210112063640
ACCESSION NUMBER:		0000885725-21-000002
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210112
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210112
DATE AS OF CHANGE:		20210112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BOSTON SCIENTIFIC CORP
		CENTRAL INDEX KEY:			0000885725
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				042695240
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11083
		FILM NUMBER:		21522382

	BUSINESS ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
		BUSINESS PHONE:		508-683-4000

	MAIL ADDRESS:	
		STREET 1:		300 BOSTON SCIENTIFIC WAY
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752-1234
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bsx-20210112.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:9695e8de-481e-43c2-bdfa-a86942b6be52,g:9aebeb48-2fb7-4148-a67f-6e62539200a0,d:ac7282c2d2b24c4d84d5bb67926d97ea--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:bsx="http://www.bostonscientific.com/20210112" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bsx-20210112</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV80L2ZyYWc6MWI4OTE1MWZmYWE0NGQzMDhkNDAzMjZlZWNiODgxNzcvdGFibGU6Y2MyNWU4NzkzZDdmNDc1ODkzMDFlMjc2ODBlZGM1ODQvdGFibGVyYW5nZTpjYzI1ZTg3OTNkN2Y0NzU4OTMwMWUyNzY4MGVkYzU4NF8yLTEtMS0xLTA_9fb420f7-d2a8-4e26-a780-26fed4516f25">0000885725</ix:nonNumeric><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV80L2ZyYWc6MWI4OTE1MWZmYWE0NGQzMDhkNDAzMjZlZWNiODgxNzcvdGFibGU6Y2MyNWU4NzkzZDdmNDc1ODkzMDFlMjc2ODBlZGM1ODQvdGFibGVyYW5nZTpjYzI1ZTg3OTNkN2Y0NzU4OTMwMWUyNzY4MGVkYzU4NF81LTEtMS0xLTA_50a7ad46-4686-4bbd-bdac-95b5b0fe2551">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bsx-20210112.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-12</xbrli:startDate><xbrli:endDate>2021-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i159ff2b70866472ea9e751c5e97173e9_D20210112-20210112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-12</xbrli:startDate><xbrli:endDate>2021-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia673c7b2a2c947af89749f616a472882_D20210112-20210112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-12</xbrli:startDate><xbrli:endDate>2021-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib525873db31f4efa98674763c0105f8a_D20210112-20210112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000885725</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-12</xbrli:startDate><xbrli:endDate>2021-01-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iac7282c2d2b24c4d84d5bb67926d97ea_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________________________________________</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU0_ffff0eea-a667-400c-94be-75e70effbfe4">8-K</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">_____________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8zNjc_e06c245c-3ae0-44b9-8ce0-97929c396545">January 12, 2021</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU1_adbca7dc-f47a-4085-9601-6f654fb27444">BOSTON SCIENTIFIC CORPORATION</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.111%"><tr><td style="width:1.0%"></td><td style="width:30.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6NDEyZmQ3Nzc4NmI3NDk4MmExMjdmODdlMzlmZWZjNWQvdGFibGVyYW5nZTo0MTJmZDc3Nzg2Yjc0OTgyYTEyN2Y4N2UzOWZlZmM1ZF8wLTAtMS0xLTA_672c222c-25b3-4f30-b340-6b254bab75e9">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6NDEyZmQ3Nzc4NmI3NDk4MmExMjdmODdlMzlmZWZjNWQvdGFibGVyYW5nZTo0MTJmZDc3Nzg2Yjc0OTgyYTEyN2Y4N2UzOWZlZmM1ZF8wLTItMS0xLTA_ceaf8c65-d0b6-4fad-a7e4-093bbacb3b51">1-11083</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6NDEyZmQ3Nzc4NmI3NDk4MmExMjdmODdlMzlmZWZjNWQvdGFibGVyYW5nZTo0MTJmZDc3Nzg2Yjc0OTgyYTEyN2Y4N2UzOWZlZmM1ZF8wLTYtMS0xLTA_a38913a8-2e69-44f0-817b-360ed8465c31">04-2695240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDUy_23ac6769-e11d-433e-b41d-40cddbc5d07c">300 Boston Scientific Way</ix:nonNumeric>, <ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU2_089cf7cd-b2ab-40f3-b487-a17b4a8772ae">Marlborough</ix:nonNumeric>, <ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU3_47895f6b-adee-462a-a9ad-96bdbbcff6ec">Massachusetts</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDUz_96c2e5cf-f174-4a3f-9a69-698a661ca426">01752-1234</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(Address of Principal Executive Offices)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;             &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;   &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;  (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU4_99744e47-afd5-4841-a4ad-cf1db68c115c">508</ix:nonNumeric> <ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU5_e68a205a-fa24-40d9-a495-ed4946915f8a">683-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:1.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ODBjOTRmZjY0N2M4NDFiNDhjM2Q2ZDNkMTAyM2JjZTUvdGFibGVyYW5nZTo4MGM5NGZmNjQ3Yzg0MWI0OGMzZDZkM2QxMDIzYmNlNV8wLTAtMS0xLTA_33023a10-c640-4823-99d3-41a933a6fda5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ODBjOTRmZjY0N2M4NDFiNDhjM2Q2ZDNkMTAyM2JjZTUvdGFibGVyYW5nZTo4MGM5NGZmNjQ3Yzg0MWI0OGMzZDZkM2QxMDIzYmNlNV8yLTAtMS0xLTA_8d40f166-e2b8-4e70-98f3-172a5a8d76bd">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ODBjOTRmZjY0N2M4NDFiNDhjM2Q2ZDNkMTAyM2JjZTUvdGFibGVyYW5nZTo4MGM5NGZmNjQ3Yzg0MWI0OGMzZDZkM2QxMDIzYmNlNV80LTAtMS0xLTA_f7ea084f-2d83-492c-84b5-1b6eaaf1454e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ODBjOTRmZjY0N2M4NDFiNDhjM2Q2ZDNkMTAyM2JjZTUvdGFibGVyYW5nZTo4MGM5NGZmNjQ3Yzg0MWI0OGMzZDZkM2QxMDIzYmNlNV82LTAtMS0xLTA_29dbf24d-d2e2-4f7a-8bff-0f56243f7c73">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:34.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i159ff2b70866472ea9e751c5e97173e9_D20210112-20210112" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18xLTAtMS0xLTA_7e877de6-c3b5-45d2-8853-fb30fdfc6bb8">Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i159ff2b70866472ea9e751c5e97173e9_D20210112-20210112" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18xLTItMS0xLTA_6657706b-7c01-4993-a1af-8656e989221a">BSX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i159ff2b70866472ea9e751c5e97173e9_D20210112-20210112" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18xLTQtMS0xLTA_233b23e5-22de-48db-847d-2466692c93ca">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia673c7b2a2c947af89749f616a472882_D20210112-20210112" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18yLTAtMS0xLTA_79f24c14-9622-42a9-8094-e8121b2eeddb">0.625% Senior Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia673c7b2a2c947af89749f616a472882_D20210112-20210112" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18yLTItMS0xLTA_3b48d5f4-e2e4-431a-8fd9-8ab6d41446d1">BSX27</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia673c7b2a2c947af89749f616a472882_D20210112-20210112" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18yLTQtMS0xLTA_eaa9fed2-c5a4-49f2-a6ad-c0d896eb61bf">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib525873db31f4efa98674763c0105f8a_D20210112-20210112" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18zLTAtMS0xLTEz_af048718-c975-460a-8269-994cd510e25a">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib525873db31f4efa98674763c0105f8a_D20210112-20210112" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18zLTItMS0xLTEz_104c2144-d2ee-4c26-8a24-3f40cb19deb1">BSX PR A</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib525873db31f4efa98674763c0105f8a_D20210112-20210112" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18zLTQtMS0xLTEz_0d1236de-2571-4c5b-8712-e4682219b203">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDYw_c0fc06b4-09b8-494b-b7d9-26594b4e4218">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="iac7282c2d2b24c4d84d5bb67926d97ea_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.02.&#160;&#160;&#160;&#160;RESULTS OF OPERATIONS AND FINANCIAL CONDITION.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;12, 2021, Boston Scientific Corporation issued a press release announcing preliminary unaudited sales results for the fourth quarter and full year ended December&#160;31, 2020. A copy of this press release is attached hereto as Exhibit 99.1.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9.01. &#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND EXHIBITS.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;Exhibits</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit No.&#160;&#160;&#160;&#160;Description</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="pressrelease-2020prelimina.htm">Press Release issued by Boston Scientific Corporation dated January 12, 2021</a></span></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104&#160;&#160;&#160;&#160;Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div id="iac7282c2d2b24c4d84d5bb67926d97ea_10"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:8.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 12, 2021</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BOSTON SCIENTIFIC CORPORATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Vance R. Brown</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vance R. Brown</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and Chief Corporate Counsel</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>pressrelease-2020prelimina.htm
<DESCRIPTION>EX-99.1 PRESS RELEASE DATED JANUARY 12, 2021
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i15e1fbbbeeb841d99ac5410927d19c37_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><img alt="letterheadlogoa441.jpg" src="letterheadlogoa441.jpg" style="height:107px;margin-bottom:5pt;vertical-align:text-bottom;width:682px"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR IMMEDIATE RELEASE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC ANNOUNCES PRELIMINARY UNAUDITED SALES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FOR THE FOURTH QUARTER AND FULL YEAR 2020</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Marlborough, Mass. (January&#160;12, 2021) -- Boston Scientific Corporation (NYSE&#58;  BSX) generated net sales, based upon preliminary unaudited financial information, of approximately $2.71 billion during the fourth quarter of 2020. This represents a decline of approximately (6.8) percent on a reported basis, approximately (8.3) percent on an operational</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> basis and approximately (8.0) percent on an organic</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> basis, all compared to the prior year period. Included within organic results is a negative 370 basis point impact associated with the conversion of U.S. WATCHMAN&#8482; customers to a consignment inventory model and transition to the next-generation WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For the full year 2020, the company generated net sales, based upon preliminary unaudited financial information, of approximately $9.91 billion. This represents a decline of approximately (7.7) percent on a reported basis, approximately (7.8) percent on an operational basis and approximately (11.3) percent on an organic basis, all compared to the prior year period. Included within organic results is a negative 170 basis point impact from WATCHMAN&#8482; discussed above.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fourth quarter preliminary financial results and recent developments&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Delivered the following fourth quarter sales growth&#47;(declines) in each reportable segment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">compared to the prior year period&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.75pt">MedSurg&#58; 1.5 percent reported, 0.1 percent operational and 1.1 percent organic</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.75pt">Rhythm and Neuro&#58; (6.1) percent reported, (7.7) percent operational and organic</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.75pt">Cardiovascular&#58; (12.0) percent reported, (13.5) percent operational and organic</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Accelerated sequential organic growth in the Peripheral Interventions business (4.8 percent organic growth), including 12 percent growth within the Interventional Medicine</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> portfolio.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Returned to growth in the MedSurg reportable segment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (1.1 percent organic growth) in the fourth quarter, driven by recovering procedural trends and favorable site of service mix. This includes a broad-based recovery in the Endoscopy business (1.5 percent organic growth), and growth within the stone and benign prostatic hyperplasia (BPH) franchises in Urology and Pelvic Health (0.6 percent organic growth).</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">WATCHMAN&#8482; and WATCHMAN FLX&#8482; Left Atrial Appendage Closure (LAAC) Device portfolio experienced strong customer demand in the fourth quarter. Organic sales declined 56 percent, which includes a negative 74 percent impact due to the conversion to a consignment inventory model and transition discussed above, and surpassed 150,000 cumulative implants worldwide.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:13.8pt">Achieved key milestones for the Neuromodulation business with the WaveWriter Alpha&#8482; portfolio of Spinal Cord Stimulator (SCS) systems including recent U.S. Food and Drug Administration (FDA) approval and third quarter 2020 launch in Europe.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Preliminary net sales for the fourth quarter by business and region&#58;</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Three Months Ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Less&#58; Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operational<br> Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Less&#58; Impact of Recent Acquisitions&#47;Divestitures</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Organic Basis</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(in billions &#47; unaudited)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Endoscopy</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.52&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.50&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3.4&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.9&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Urology and Pelvic Health</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.38&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.38&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">MedSurg</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.89</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.88</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(1.0)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.45&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.47&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(4.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Electrophysiology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.08&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Neuromodulation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.23&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.26&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(11.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rhythm and Neuro</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.77</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.82</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(6.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interventional Cardiology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.58&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.75&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(21.9)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(23.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Peripheral Interventions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.43&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.40&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.5&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.7&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cardiovascular</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.01</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(12.0)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(13.5)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(13.5)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Medical Devices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.85</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(6.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(0.3)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.4)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(38.5)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(38.8)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.0</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(38.8)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.71</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(6.8)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(8.3)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(0.3)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(8.0)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Three Months Ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Less&#58; Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operational Basis</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(in billions &#47; unaudited)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.50&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.65&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.2)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.2)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EMEA</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.59&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.60&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.9)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">APAC</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.49&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.49&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5.6)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Latin America and Canada</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.09&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(10.5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Medical Devices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.67</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.85</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(6.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.04</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.06</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(38.5)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(38.8)</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.71</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.90</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(6.8)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">1.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(8.3)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Preliminary net sales for the full year by business and region&#58; </font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.536%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change</font></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Less&#58; Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operational<br> Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Less&#58; Impact of Recent Acquisitions&#47;Divestitures</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Organic Basis</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(in billions &#47; unaudited)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Endoscopy</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.78&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.89&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.0)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.3&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.3)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.3)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Urology and Pelvic Health</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.29&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.41&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1.7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.3)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">MedSurg</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">3.07</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">3.31</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.3)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.5)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(0.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(6.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cardiac Rhythm Management</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.70&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.94&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Electrophysiology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.29&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.33&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Neuromodulation</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.76&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.87&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(12.8)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(13.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.8&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.7)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Rhythm and Neuro</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.75</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">3.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(12.4)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(12.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(13.4)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interventional Cardiology</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.30&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.82&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(0.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(18.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Peripheral Interventions</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.58&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.39&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.3&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.2&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">13.1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">15.6&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2.5)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cardiovascular</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">3.88</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">4.21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.9)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(0.0)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.9)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(13.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Medical Devices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">9.69</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">10.65</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(9.0)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(9.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(11.2)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">n&#47;a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">n&#47;a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">n&#47;a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">n&#47;a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">n&#47;a</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">9.91</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">10.74</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.7)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.8)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">3.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(11.3)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.451%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Change</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Twelve Months Ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Reported Basis</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Less&#58; Impact of Foreign Currency Fluctuations</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Operational Basis</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(in billions &#47; unaudited)</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">U.S.</font></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5.51&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</font></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">6.10&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.0&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(9.7)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">EMEA</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.10&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2.26&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(8.4)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">APAC</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.78&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.90&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(6.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1.0&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.1)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Latin America and Canada</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.31&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">0.39&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(22.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(7.0)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(15.2)</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Medical Devices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">3</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">9.69</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">10.65</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(9.0)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(9.1)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Specialty Pharmaceuticals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:700;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">4</font></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.22</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.08</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">n&#47;a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">n&#47;a</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">n&#47;a</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net Sales</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">9.91</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">10.74</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.7)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">0.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(7.8)</font></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">%</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Net sales growth rates that exclude the impact of foreign currency fluctuations and&#47;or the impact of recent aforementioned acquisitions &#47; divestitures are not prepared in accordance with U.S. GAAP. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All of the information in this press release is preliminary and subject to completion of year-end financial reporting processes, reviews and audit.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">1. Operational net sales growth rates exclude the impact of foreign currency fluctuations.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">2. Organic net sales growth rates exclude the impact of foreign currency fluctuations and net sales from the recent acquisitions of Vertiflex, Inc. and BTG plc (BTG), each with no prior year comparable net sales. Organic net sales growth rates also exclude the impact of the divestiture of our global embolic microspheres portfolio, a transaction entered into in connection with obtaining the antitrust clearances required to complete the BTG transaction, as well as prior period net sales associated with our intrauterine health franchise, which we divested in Q2 2020.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">3. We have three historical reportable segments comprised of Medical Surgical (MedSurg), Rhythm and Neuro, and Cardiovascular, which represent an aggregation of our operating segments that generate revenues from the sale of medical devices (Medical Devices). As part of our acquisition of BTG on August 19, 2019, we acquired an Interventional Medicine business, which is now included in our Peripheral Interventions operating segment's revenues from the date of acquisition. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">4. As part of our acquisition of BTG on August 19, 2019, we acquired a specialty pharmaceuticals business (Specialty Pharmaceuticals). Subsequent to acquisition, Specialty Pharmaceuticals is now a stand-alone operating segment presented alongside our Medical Device reportable segments. Specialty Pharmaceuticals net sales are substantially U.S. based. Our chief operating decision maker (CODM) reviews financial information of our globally managed Specialty Pharmaceuticals operating segment at the worldwide level without further disaggregation into regional results. As such, Specialty Pharmaceuticals net sales are presented globally, and our Medical Devices reportable segments regional net sales results do not include Specialty Pharmaceuticals. In Q4 2020, we signed a definitive agreement to sell Specialty Pharmaceuticals. The sale is expected to close in the first half of 2021, pending customary closing conditions.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">J.P. Morgan Healthcare Conference on Tuesday, January&#160;12, 2021 </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Also as previously announced, Boston Scientific will participate in the virtual J.P. Morgan Healthcare Conference today. Mike Mahoney, chairman and chief executive officer, will present at approximately 8&#58;20 a.m. EST. At 8&#58;40 a.m. EST, Mike will be joined by Dan Brennan, executive vice president and chief financial officer, Dr. Ian Meredith, executive vice president and global chief medical officer, and Susie Lisa, vice president, Investor Relations, in a question-and-answer session with the host analyst and audience members. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A live webcast of the presentation and question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">investors.bostonscientific.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A replay of the webcast will be accessible at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">investors.bostonscientific.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> beginning approximately one hour following the completion of the event.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conference Call on Wednesday, February&#160;3, 2021</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As previously announced, Boston Scientific will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2020 on Wednesday, February&#160;3, 2021 at 8&#58;00 a.m. EST. A live webcast of the conference call will be available on the Investor Relations section of the website at </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">investors.bostonscientific.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A replay of the webcast will be archived and available at&#160;</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">investors.bostonscientific.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;beginning approximately one hour following the completion of the meeting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Boston Scientific</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.&#160;As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">www.bostonscientific.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and connect on </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Twitter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Facebook</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cautionary Statement Regarding Forward-Looking Statements</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like &#34;anticipate,&#34; &#34;expect,&#34; &#34;project,&#34; &#34;believe,&#34; &#34;plan,&#34; &#34;estimate,&#34; &#34;intend&#34; and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our expected net sales, GAAP, operational and organic revenue growth rates and our financial performance. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our expectations about quarterly and full year results are based on preliminary unaudited information about the fourth quarter of 2020 and are subject to revision. Although the quarter is now completed, we are still in the early stages of our standard financial reporting closing procedures. Accordingly, as we complete our normal quarter-end and year-end closing and review processes, actual results could differ materially from these preliminary estimates. Factors that could cause our actual results for the fourth quarter of 2020 to differ materially from those contemplated by these forward-looking statements include, but are not limited to, inaccurate assumptions&#59; changes in estimates or judgments&#59; and facts or circumstances affecting the application of the company&#8217;s critical accounting policies, including revenue recognition.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Factors that may cause such differences include, among other things&#58; future economic, political, competitive, reimbursement and regulatory conditions&#59; new product introductions&#59; demographic trends&#59; intellectual property&#59; litigation&#59; financial market conditions&#59; and future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item IA- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Note</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; Amounts reported in billions within this press release are computed based on the amounts in thousands.&#160;As a result, the sum of the components reported in billions may not equal the total amount reported in billions due to rounding. Certain columns and rows within tables may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in dollars.</font></div><div><font><br></font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Use of Non-GAAP Financial Information</font></div><div style="padding-right:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A reconciliation of the company's non-GAAP financial measures to the corresponding GAAP measures, and an explanation of the company's use of these non-GAAP financial measures,&#160;is included in the exhibits attached to this press release.</font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:16.055%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CONTACT&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Media&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kate Haranis</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Investors&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Susie Lisa, CFA</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">508-683-6585 (office)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">508-683-5565 (office)</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Media Relations</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Investor Relations</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Boston Scientific Corporation</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">kate.haranis&#64;bsci.com</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:174%;text-decoration:underline">BSXInvestorRelations&#64;bsci.com</font></div></td></tr></table></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i15e1fbbbeeb841d99ac5410927d19c37_4"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">BOSTON SCIENTIFIC CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">NON-GAAP NET SALES RECONCILIATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Unaudited)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WATCHMAN&#8482; Revenue Growth</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:60.672%"><tr><td style="width:1.0%"></td><td style="width:79.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.178%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Q4 2020</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Revenue growth, as reported</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(55)</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less&#58; Impact of foreign currency fluctuations</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less&#58; Impact of recent acquisitions &#47; divestitures</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Revenue growth, organic</font></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(56)</font></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i15e1fbbbeeb841d99ac5410927d19c37_10"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Non-GAAP Financial Measures</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To supplement our financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including operational net sales, which exclude the impact of foreign currency fluctuations, and organic net sales, which exclude the impact of foreign currency fluctuations and the impact of recent aforementioned acquisitions and divestitures. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States and should not be considered in isolation from or as a replacement for the most directly comparable GAAP financial measures. Further, other companies may calculate these non-GAAP financial measures differently than we do, which may limit the usefulness of those measures for comparative purposes.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To calculate operational net sales growth rates, which exclude the impact of foreign currency fluctuations, we convert actual net sales from local currency to U.S. dollars using constant foreign currency exchange rates in the current and prior period. To calculate organic net sales growth rates, we remove the impact of recent aforementioned acquisitions with no prior period related net sales from operational net sales. In addition, to calculate organic net sales growth rates, we remove from prior year, sales from product lines that we divested. The GAAP financial measure most directly comparable to operational net sales and organic net sales is net sales on a GAAP basis. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Reconciliations of each of these non-GAAP financial measures to the corresponding GAAP financial measure are included in the accompanying schedules.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Management uses these supplemental non-GAAP financial measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors and to establish operational goals and forecasts that are used in allocating resources. In addition, management uses these non-GAAP financial measures to further its understanding of the performance of our operating segments. The adjustments excluded from our non-GAAP financial measures are consistent with those excluded from our operating segments&#8217; measures of net sales. These adjustments are excluded from the segment measures reported to our chief operating decision maker that are used to make operating decisions and assess performance.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We believe that presenting operational net sales and organic net sales, in addition to the corresponding GAAP financial measures, provides investors greater transparency to the information used by management for its operational decision making and allows investors to see our results &#8220;through the eyes&#8221; of management. We further believe that providing this information assists our investors in understanding our operating performance and the methodology used by management to evaluate and measure such performance.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>bsx-20210112.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9695e8de-481e-43c2-bdfa-a86942b6be52,g:9aebeb48-2fb7-4148-a67f-6e62539200a0-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bsx="http://www.bostonscientific.com/20210112" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bostonscientific.com/20210112">
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210112_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210112_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210112_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bsx-20210112_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverDocument" roleURI="http://www.bostonscientific.com/role/CoverDocument">
        <link:definition>0001001 - Document - Cover Document</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bsx_SeniorNotedue2027Member" abstract="true" name="SeniorNotedue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="bsx_A550MCPSSeriesAMember" abstract="true" name="A550MCPSSeriesAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>bsx-20210112_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9695e8de-481e-43c2-bdfa-a86942b6be52,g:9aebeb48-2fb7-4148-a67f-6e62539200a0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20210112.xsd#CoverDocument"/>
  <link:calculationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>bsx-20210112_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9695e8de-481e-43c2-bdfa-a86942b6be52,g:9aebeb48-2fb7-4148-a67f-6e62539200a0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20210112.xsd#CoverDocument"/>
  <link:definitionLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended" id="i374603ac9ac94167831ab77f46dbf34c_CoverDocument">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9b4edd70-9a32-4773-93bb-03ee6ea84276" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_DocumentType_9b4edd70-9a32-4773-93bb-03ee6ea84276" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d7a9a86f-a0ad-44cc-a95a-461566bb678a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_DocumentPeriodEndDate_d7a9a86f-a0ad-44cc-a95a-461566bb678a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_846e0447-c9c3-4c05-a56b-24cf7325a9cf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityRegistrantName_846e0447-c9c3-4c05-a56b-24cf7325a9cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6f911543-5194-444f-81b5-5ece716112f2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_AmendmentFlag_6f911543-5194-444f-81b5-5ece716112f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a2e1597f-47dd-42fb-841a-df5ef1112cf1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a2e1597f-47dd-42fb-841a-df5ef1112cf1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9dcf9a7e-9f62-4ec4-ba04-f0fe648382ca" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityFileNumber_9dcf9a7e-9f62-4ec4-ba04-f0fe648382ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d94f9450-471b-43d0-ab84-71cbd00c43db" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityTaxIdentificationNumber_d94f9450-471b-43d0-ab84-71cbd00c43db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_64fcb00e-daa5-40bf-ab77-f6df7055e394" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityAddressAddressLine1_64fcb00e-daa5-40bf-ab77-f6df7055e394" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_981ab28a-a35b-4a67-a38a-a01d136550b9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityAddressCityOrTown_981ab28a-a35b-4a67-a38a-a01d136550b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6d93099d-a4af-4f59-8c18-be485330be0e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityAddressStateOrProvince_6d93099d-a4af-4f59-8c18-be485330be0e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_060b9a3e-d284-4495-8d49-94ee29a7cfe0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityAddressPostalZipCode_060b9a3e-d284-4495-8d49-94ee29a7cfe0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_08c9c3d5-3dab-463c-ac36-512b9b3ed6a7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_CityAreaCode_08c9c3d5-3dab-463c-ac36-512b9b3ed6a7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1f3d0138-0ef0-4d34-9920-8adebab79f8f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_LocalPhoneNumber_1f3d0138-0ef0-4d34-9920-8adebab79f8f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9d8c266f-8da9-4253-9260-a061dc71161b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_WrittenCommunications_9d8c266f-8da9-4253-9260-a061dc71161b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_77d5908a-c8c1-41c7-beda-375d6e3b58f9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_SolicitingMaterial_77d5908a-c8c1-41c7-beda-375d6e3b58f9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_15e053e0-44bf-4ac3-ba93-68f458a55dd3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_PreCommencementTenderOffer_15e053e0-44bf-4ac3-ba93-68f458a55dd3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_81a97777-1fb7-4d63-8477-a827d6f61661" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_81a97777-1fb7-4d63-8477-a827d6f61661" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e5f19ee5-db14-4d4c-8dfe-df9d1b1b36f4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_Security12bTitle_e5f19ee5-db14-4d4c-8dfe-df9d1b1b36f4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dc9ea25e-99b6-4ca2-b8ae-8c6776250d2b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_TradingSymbol_dc9ea25e-99b6-4ca2-b8ae-8c6776250d2b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_951eeaa8-215a-45e7-93a5-ed0f56cc481d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_SecurityExchangeName_951eeaa8-215a-45e7-93a5-ed0f56cc481d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_69c92bf0-d312-4e62-b100-555343815801" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityEmergingGrowthCompany_69c92bf0-d312-4e62-b100-555343815801" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_48c7b229-1de9-428d-b0ba-de0d85b1984b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityCentralIndexKey_48c7b229-1de9-428d-b0ba-de0d85b1984b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_89bd7083-0df8-473a-ba3b-4e6b5add3b55" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntitiesTable_89bd7083-0df8-473a-ba3b-4e6b5add3b55" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_744e4d87-ee1d-4b45-8060-b0897ad42645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_89bd7083-0df8-473a-ba3b-4e6b5add3b55" xlink:to="loc_us-gaap_StatementClassOfStockAxis_744e4d87-ee1d-4b45-8060-b0897ad42645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_744e4d87-ee1d-4b45-8060-b0897ad42645_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_744e4d87-ee1d-4b45-8060-b0897ad42645" xlink:to="loc_us-gaap_ClassOfStockDomain_744e4d87-ee1d-4b45-8060-b0897ad42645_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_744e4d87-ee1d-4b45-8060-b0897ad42645" xlink:to="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_84136965-7efa-4424-8544-f6a48284cfd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:to="loc_us-gaap_CommonStockMember_84136965-7efa-4424-8544-f6a48284cfd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_abfbfcea-e026-4576-b14a-7da388c480c6" xlink:href="bsx-20210112.xsd#bsx_SeniorNotedue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:to="loc_bsx_SeniorNotedue2027Member_abfbfcea-e026-4576-b14a-7da388c480c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_f1993d89-f110-43e9-9917-eba16cb11526" xlink:href="bsx-20210112.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:to="loc_bsx_A550MCPSSeriesAMember_f1993d89-f110-43e9-9917-eba16cb11526" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bsx-20210112_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9695e8de-481e-43c2-bdfa-a86942b6be52,g:9aebeb48-2fb7-4148-a67f-6e62539200a0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_bsx_A550MCPSSeriesAMember_9456f46d-fd1f-4f30-8fd0-fa279a826fa5_terseLabel_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_label_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A [Member]</link:label>
    <link:label id="lab_bsx_A550MCPSSeriesAMember_documentation_en-US" xlink:label="lab_bsx_A550MCPSSeriesAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% MCPS, Series A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember" xlink:href="bsx-20210112.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_A550MCPSSeriesAMember" xlink:to="lab_bsx_A550MCPSSeriesAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d551e2f5-a567-4dcf-9993-0e69f85bd5f3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_a174c83d-729f-45b6-a24f-56e8fd40626d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_7715a4aa-0087-4432-b7b1-3128f373a716_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_f7d35aed-bb93-41da-814d-25dc6c010067_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a1924ffd-6c5d-4cbb-bcdf-6cd11738b116_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_80f3cacd-73d4-4515-b078-8b1c62a7eba0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ce49887b-2343-4862-bbb1-bfadd484dddd_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_2a56b773-1cc0-4dc4-ae87-78848c797a01_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c504622d-c747-411e-94fe-1edd1bb4dc64_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_bde09a5e-d040-495d-a51a-847da44b4720_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f656c3c4-7bd7-48dd-b33d-269efe42eac8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_38d788a9-de81-4a99-b2a4-268e227501b3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_88ee2560-3b00-456f-b040-bc8a5adf2f8b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_de994a16-0ee2-40b3-96d5-d7ba41ff1bdc_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1fcc1273-ba95-4197-a46d-bf4ff2fd5636_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9db73a05-9879-48a8-88db-61e5d1e7735c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_387fd095-598a-4296-9b4c-28b59b28daad_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b521d532-013a-45f6-a4e6-de56988b9b52_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a82028f5-6f7d-4b98-afde-6d2bb9e6a9bb_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_bsx_SeniorNotedue2027Member_e49bcb2d-2075-4d26-81c1-4a977f92a789_terseLabel_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_label_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:label id="lab_bsx_SeniorNotedue2027Member_documentation_en-US" xlink:label="lab_bsx_SeniorNotedue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Note due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member" xlink:href="bsx-20210112.xsd#bsx_SeniorNotedue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bsx_SeniorNotedue2027Member" xlink:to="lab_bsx_SeniorNotedue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7df6c1b5-a804-4930-be66-7d86a46a17da_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_e92ad416-1d1a-429c-b9bf-742828af9a79_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_da1a1f38-182e-47ec-904e-a480d89fe7fb_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c7e8cc17-0e49-42bf-9353-e6fe2061350d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c72ad7b6-7d58-4c4f-94ea-2941bfa33aa2_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_caa22cd9-3e46-41e1-a240-bdbc32a44e7c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_532ed4ee-6e36-4264-b234-386dad5437af_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_abc59219-7256-4c10-9da9-aa242d57e03b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_da8428dd-8412-4457-afda-c17190a99e48_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bsx-20210112_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:9695e8de-481e-43c2-bdfa-a86942b6be52,g:9aebeb48-2fb7-4148-a67f-6e62539200a0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bostonscientific.com/role/CoverDocument" xlink:type="simple" xlink:href="bsx-20210112.xsd#CoverDocument"/>
  <link:presentationLink xlink:role="http://www.bostonscientific.com/role/CoverDocument" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e4d91922-6a6a-4891-b463-276ca372f34e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_89bd7083-0df8-473a-ba3b-4e6b5add3b55" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e4d91922-6a6a-4891-b463-276ca372f34e" xlink:to="loc_dei_EntitiesTable_89bd7083-0df8-473a-ba3b-4e6b5add3b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_744e4d87-ee1d-4b45-8060-b0897ad42645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_89bd7083-0df8-473a-ba3b-4e6b5add3b55" xlink:to="loc_us-gaap_StatementClassOfStockAxis_744e4d87-ee1d-4b45-8060-b0897ad42645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_744e4d87-ee1d-4b45-8060-b0897ad42645" xlink:to="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_84136965-7efa-4424-8544-f6a48284cfd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:to="loc_us-gaap_CommonStockMember_84136965-7efa-4424-8544-f6a48284cfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_SeniorNotedue2027Member_abfbfcea-e026-4576-b14a-7da388c480c6" xlink:href="bsx-20210112.xsd#bsx_SeniorNotedue2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:to="loc_bsx_SeniorNotedue2027Member_abfbfcea-e026-4576-b14a-7da388c480c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bsx_A550MCPSSeriesAMember_f1993d89-f110-43e9-9917-eba16cb11526" xlink:href="bsx-20210112.xsd#bsx_A550MCPSSeriesAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_50351236-2632-48e7-97a9-1fa0e83acb5d" xlink:to="loc_bsx_A550MCPSSeriesAMember_f1993d89-f110-43e9-9917-eba16cb11526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_89bd7083-0df8-473a-ba3b-4e6b5add3b55" xlink:to="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9b4edd70-9a32-4773-93bb-03ee6ea84276" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_DocumentType_9b4edd70-9a32-4773-93bb-03ee6ea84276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d7a9a86f-a0ad-44cc-a95a-461566bb678a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_DocumentPeriodEndDate_d7a9a86f-a0ad-44cc-a95a-461566bb678a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_846e0447-c9c3-4c05-a56b-24cf7325a9cf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityRegistrantName_846e0447-c9c3-4c05-a56b-24cf7325a9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6f911543-5194-444f-81b5-5ece716112f2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_AmendmentFlag_6f911543-5194-444f-81b5-5ece716112f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a2e1597f-47dd-42fb-841a-df5ef1112cf1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a2e1597f-47dd-42fb-841a-df5ef1112cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9dcf9a7e-9f62-4ec4-ba04-f0fe648382ca" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityFileNumber_9dcf9a7e-9f62-4ec4-ba04-f0fe648382ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_d94f9450-471b-43d0-ab84-71cbd00c43db" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityTaxIdentificationNumber_d94f9450-471b-43d0-ab84-71cbd00c43db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_64fcb00e-daa5-40bf-ab77-f6df7055e394" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityAddressAddressLine1_64fcb00e-daa5-40bf-ab77-f6df7055e394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_981ab28a-a35b-4a67-a38a-a01d136550b9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityAddressCityOrTown_981ab28a-a35b-4a67-a38a-a01d136550b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6d93099d-a4af-4f59-8c18-be485330be0e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityAddressStateOrProvince_6d93099d-a4af-4f59-8c18-be485330be0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_060b9a3e-d284-4495-8d49-94ee29a7cfe0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityAddressPostalZipCode_060b9a3e-d284-4495-8d49-94ee29a7cfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_08c9c3d5-3dab-463c-ac36-512b9b3ed6a7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_CityAreaCode_08c9c3d5-3dab-463c-ac36-512b9b3ed6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_1f3d0138-0ef0-4d34-9920-8adebab79f8f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_LocalPhoneNumber_1f3d0138-0ef0-4d34-9920-8adebab79f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_9d8c266f-8da9-4253-9260-a061dc71161b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_WrittenCommunications_9d8c266f-8da9-4253-9260-a061dc71161b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_77d5908a-c8c1-41c7-beda-375d6e3b58f9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_SolicitingMaterial_77d5908a-c8c1-41c7-beda-375d6e3b58f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_15e053e0-44bf-4ac3-ba93-68f458a55dd3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_PreCommencementTenderOffer_15e053e0-44bf-4ac3-ba93-68f458a55dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_81a97777-1fb7-4d63-8477-a827d6f61661" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_81a97777-1fb7-4d63-8477-a827d6f61661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e5f19ee5-db14-4d4c-8dfe-df9d1b1b36f4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_Security12bTitle_e5f19ee5-db14-4d4c-8dfe-df9d1b1b36f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dc9ea25e-99b6-4ca2-b8ae-8c6776250d2b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_TradingSymbol_dc9ea25e-99b6-4ca2-b8ae-8c6776250d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_951eeaa8-215a-45e7-93a5-ed0f56cc481d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_SecurityExchangeName_951eeaa8-215a-45e7-93a5-ed0f56cc481d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_69c92bf0-d312-4e62-b100-555343815801" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityEmergingGrowthCompany_69c92bf0-d312-4e62-b100-555343815801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_48c7b229-1de9-428d-b0ba-de0d85b1984b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_599668ac-7466-4112-91d8-02ea0bd486a2" xlink:to="loc_dei_EntityCentralIndexKey_48c7b229-1de9-428d-b0ba-de0d85b1984b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>letterheadlogoa441.jpg
<TEXT>
begin 644 letterheadlogoa441.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" $%!G(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#\RF19!EE5
MA[BH9-+MY.L2@GN.*R(=<N8\;G#@=B*GB\1L,!XP3['%?JKG'J?GEF69?#T+
M#*M(AS]:A?PZX!V2JP Z$8J:+7X),;MZ8]15B+48I2 LBDGMGFFDF%V9;:)<
MQC[@;Z'-026LD6=T;KCU%="DP)SNX'XT\2 CDY'>CE#F9S8.!C!R*7TK>E@@
MF)W1(2?89J!M&@?D;T^AH<0<C*53GGM3U4]>QJ\^@D+F.53[$8J"33KB+JA8
M#J1S19DW(T4="V,5)N7J, BH#E#@@J1ZB@2$'-),9.LHSTXIQ;(' YJ .#VX
M-+N.1U--,2)P2K*,9/M4R.3V.?:J@?GDG(IZ.>>2!5(EHO12-&,IO4GDGD5:
MM=?N[(@I/,H_WCBLL.W&&/'O3HYG5@0QIIB.FL?B#?P_>F9QCN :UK+XFR@
M2@$>NVN'CNI/[Q%2"\D!SO:J4A-'HUIXXM[LX=8&^ORU<74K.= 3&03T*/FO
M,$U"1.2P)^E2Q:K-&05?!'3 YJU(AQ9Z4]S;D_*[J3V(R?TI/ML:@9<'/M7
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M!JQ"1@\9!JI#*AQAE;\:L"4D8Z$521-RSY@(P3TI>"  :KHPR#D9-2)PPP0
M*M(+DFW<1QG'I4\63DYP#4*MM<'I4@DSCG(%!+)&M8IL[HXV^J@U!)H5G*?F
MMXR?4<5)YW)&1^=21N"2.M KE!O!UE,00LB$^C<57G\"1'F.X<'_ &ES6[&0
M/I3CSQG-%AW.7E\ W"J1'-$XZ#@BJLW@O4$!)C5\?W6!S7;(I; YYJ583Z9_
M&FH)DN1Y^/#]S <O:S+]%S_*GI9O 065D/OD&O0E4)R>]*Z))RRJ0?4"GRD\
MQYYYTJ@;9'  _O$4QM0GC7*RRY_WS7>S:-9S@AK:%C_N@&JLG@?3[AB3$Z$_
MW7.!1RL')'#QZC>L^1<2C'058M]1OP1_I$A],@$5U?\ PKBWYV3RJ>VX XIC
M> )H\>7-$Y'3.1FA)DW1A)K%ZB'+HS8[J*F7Q%>H"0(C_P !Q5RY\&WZMA85
M<#T8&J[Z)=VWW[690.IV&JLPNAH\07!R7BC(SZD5+_PDA RT /T)JI,#&<LK
M ^A&*B"-(00./TH$TC3'B:)20T#@_45)%KEM,QRDH)]JSH;4G+,,YJ00@9P.
M>E.Y)IIK%FA!+2+GC[N:F.L6*YS.J$=<@UA20;V&5.3UIATHR\\FG<#HXM1L
MY<!;F$Y']ZIH6@<\2PD>S"N9&C8RV"3^M-;2FWD $'&>.M--DN)V<$$93((;
M'?K22PI( -BL1ZUQJ:5-@9>0 >YJVME<Q %+B92!ZFG8DWY-,@)W&&,GJ?E%
M0R^'K:0C= ASZ#%9T(OE&!=S$'^\<U?MKJ]VY,N_ [H,4TQ#9/"=K+P(54CT
M)%5Y/!,++PKC'^UBM-=5G@/S)$WU!%077B]K9<M;HQZ<-BJLMR+F9)X*1.49
MU'N<U$WA @DB4C'M6F/&\,F-]LZ@>C T]/%=DS$E9T!ZY (H20&&WA>4\J^<
M^U._X1.X^4@H"><=*Z&#7M/?@RXW?WE-6XKZREX%Q 2>GSX-4D)LY"3PO=1D
MDQJV/0TP:+.I!,;5VR6Z3#*.C ]]P-2KX=\Z 2%R67H1VI\I/,<$=/D0Y,;
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M 3P< ]>*4D9R.".U-& N1QGTHST!P:9FQ>,G.0*7@\ DFFDGD]":<.F3QZ4
M"DD@9.,_G4H.2,@9J)>2.2<U(H.<$9/>@3!@"<#C%,<$ !1FI. >>U1D_,"W
M0=*T0QH W9!P*7! /.1]*;RK\CD]J=G;R,XZT$2$8[C@$CZ\8I=H!R0,4T>N
M<YH+$8!P#0(1^" ,8-'<<<4N/F!P>:  ,X(Q^5   23V[T;1DDX)HP>1UI.G
M!S@4 *<^6/2FCH,YYI<'!)H0=<]#02]F&!C.,TO?C Q0<@  $#I2,<8 P!VH
M) \DY&0:85 'MWIQ8DG!!H)X/44 -Z9R ,]J9*^T<8%*S%??-1,<MR<'M[4
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M<58@GN4!"S3)CL&(%=.WA6;>2$C8GWJ";PS<*#^[)(]"#GVH29+9C1ZW?0G
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M-F0<\TQV R 1S2D D@ <4A! ZYQ0 W<.@)/Z4S)+$\ "I H))(P#2$'IZ=:
M(^2..IHV9P3@D&GXYX.::>#P,@?K0 P@;1@#TXII7D$X!'%2,"V <X'Z4TJ
M,<T 1@<]S28'('!]ZD5<'@ ^YZT,I/'0B@"$KZ FCE<<#GUJ;R\<^GZTOE G
M.#@4 5B@))/4'\*0H> !P.M660=N!32F%!'X4 0&,DC- C(P.I%2X QR32%L
MY(P30!$%P"<4,"#GUIQ)+C'2FD'TZT ,*C!& *:2 >!FGE#WXI/+&<X&30!&
MQ (  !IN3C(YJ8H0!U)/M32,9! (% $)4MW!)IOEYQR<"IRF" >/>FE3Z8Q0
M!7,?7BC: 2!@BI60YX!&*3R^0,#!H A901P,TTH<8')%3^5UP"!0(2W&#S0!
M!Y>,9P33&49.0>:M>1U'.:/LOH,@=: *80Y&03_*CR6;@ _E5Y;,L22,$4_[
M"%4\CF@#-,![GK1]E+<8SBM$01YP,$#FAF5<8!)% &>;0]-I.?:GQV0(Y %6
MB7=N!BD,3,.21B@"M]D4$YR?2G-&HX& !4P@&0<\BD:'VS_2@" [1V%-8]<+
MQ[U8* $8YIR64DN-J'^0H J8;^[16@-'E[E ?K10!\U;^?I2;B,Y/)I2I!HV
M'D<8%?F2=S]@$.?6I(9I$/#L />HPASZ4_!QU !I/31 T3QZC(@R2KX]J?\
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MZ$"H"1@@4-$&.2.E3^0.,9%(R$X[DTTA$)0E@"/\*7R=P )(QVJ4)@G(_2G
MYQG'% %?R0<G:3FD\KG../UJPP]LBF'!QU!%-,F3(?+')YXI8T# C'/\J>06
M!  ('ZT(I08& 3UJB1IQG(P11M"L,@@&GXPQ]J7&2"<8II: 0;21P0*4QG:2
M0":D(SG!!(Y%*!P,G![T)B;(P!O.1G'2C;P",5+@=>#GI2*@;C)R*J.P)B)D
MCGD8H &"#WIX0#.#G'X4I3K@$DTR&B,YQV)I!PV>#Q3]F3G.".M 0[@!@\?2
M@3$C4[5QBG2#( '3VI3@#/.!^%(<$=: 1&5SD=":.G()IQR1P,@<4A&>N*T2
M&"Y#=3^-*6..U(I!;).2*/O<=J");C=PR23S2$$D\@BEQSR"*3:<]#UH$"("
MP!YQ3FR"#G.?6D4$$D\ >E(Q(.2,@4 !]R03^M 7^'D@4O7(P#BE(&TC&* $
M 'J31@\@ @4O\6/2@(3P3P*"),:0,]\4,#@'%2"/W)I& '8\T"(F/ XP12;0
M2.1FG^61SMQBDV@XY H 39M!QC%,.><<5(W (&1FF $^W]: $(&,G(%-.3QP
M<4\IP <\TTK\O!- #22>.!BF@9!R3S4HBR!G(-(R!20,D^] $8[@9I=A..II
MXCR>#R*4J,D\$F@"(J#CD9%-9,=,Y^E2[!DDD<TC\'N: (@A YXQQZ4P@G)Q
M_A4^P$DYI/+S@ 8';TH B"@G R:0H!G!SFIQ"<YZ'I1Y8!'&: (#&6!!IOED
MGH<58$8  ZTK(!C(!S0!7$6 ?:D,?/3BIR ,$G&/RI"=Q( ! H @('09H*\9
MSD5(R%NI  ]J8(SSR3GKWH 8P!/4FF9)/.3CIQ4P0 9.<_I0(^"#@&@"N4;G
MT-(4.0  *G*\YY%'ECJ ,?2@"N$P.V<T%,X/>IMF,XZ?G2;.<^E $.P\XZ'K
M3?+QWP*G*C@#)I-H.0 #B@" QCC.233?+ST&*L-"6P?0T"W)//>@"MY>.IH*
M'!QG-6C;COBE$/08% %+RRQX!.:4PE@< @&KJVX!QD#'ZTHA5&)/./RH H+:
MCD8.*=]C.,A:O 83A"/KS3 LC$$C _2@"M]CQC(&/3-(L"XSE1[59,#2,2V,
M4GV7ID9 ]* *LB*I!4%FI0Q(PJG/O5L6^3P,?3BD: ].F: *;1R.=V>!TIK0
M,^,Y]JO&# P#FD$&>Q% %06JKR<D4>4.< XJW]G);"JS'Z9J:+2)7Y("#U/%
M &;Y1]#@T>42< $UL)HR(?F8MCMTJ1;98^$55 ]N: ,9-,EE (0@>_%/;38X
M>990#TP*TY+4R??9F'IG I@LDZA5!_.@+&;YD49_=1%R.Y%#M<39PA0'TK2,
M(&<=J:T87J*&RE%F5]CG]?UHK2^7U%%*X^0^7WL %PA)!ZDCFHQ:%'!93M'6
MM!IML> %_+FJTUX-FT(H([D<U^:L_6;E:15#';G!]:;E6(R#@>E/1OE("!CZ
MT^&+(VB/<3W]*0,AVCGOFGQJJL P)'L<5<CLD2,;E);ZU/'I:LF0C+[D]*:B
MP;,]553DY-2+'YA(56..GH*GD@BM"25:0CVP*KSS.YQRJCMC %#0'I_[#^G0
M:E^VK\'[6ZAAN+>X\;:+%-%*H>.56OX0RLIX((."#US7]:?_  I;P;_T*7AG
M_P %<'_Q-?Q[_"GXAW_P@^*/AOQ;I:P2:GX7U6VU>T6=2T1FMYDE0, 1E=R#
M(R.*_7C]B+_@Y(^,?[2'[67PX\ :UX6\"6^F>+=<M=+O+BV@N%F5)'"LR9D(
M#>F017SN>8*M6<:E/:*=]3VLHQ=*E>%3=M6/V0_X4KX-/7PEX8_\%<'_ ,37
MQ[_P6S_X)E:%^UM^Q;K,OA+PWI-EXZ\%JVLZ.]E91PS78129K7*@%A(@.!_?
M5*^YUR!S0ZAU((!!ZYZ5\G0Q$Z52-2+U1])6H0J0<)+1G\7A,MM(Z2!E9"05
M88(([&ON;_@W9\*Z3X[_ ."H_@^TUK3+'5+:'3=3G2&ZA6:,.MI)M;:P(R,Y
M'H:O?\'!/[ !_8X_;(NO$6AV1M_!/Q*,FKV)C7$5I=ER;FV'IAB' _NR8[5\
MN_L8_M>>*?V&OV@='^(_@Y=/FUK1XYX4BOHC)!,DT31NK*"#T;C!&"!7Z%.?
MUK"-TG\2=O4^*C'ZOB4JGV6KG]9G_"EO!W_0I^&2?^P7!_\ $T?\*6\&_P#0
MI>&?_!7!_P#$U^6G_!)W_@O?\4OV[_VU?#_PW\4>&_!VG:1JEG>7$L^GQ3K.
MK0P-(N"TA&"5YXZ5^N-?!8O#5L-/V=7>U]S['#8BE7AST]CF?^%+>#NO_")>
M&0?^P7!_\37\Z_\ P<>^$M+\'?\ !3/6;;2--L-+MYM%L)GBM+=849S&06*J
M ,D <^U?=O\ P5X_X+M_$W]@#]LN^^'?A;PYX0U/2+72[.^6;48YFG+S(689
M5P, CCBOR!_;6_;3\2_MY?'>]^('C*#3+75[RWBM1#8PF."*.-=J@ DDGJ<D
M]Z^BR' 5X5%7G\+7?O8\3.,91G!T8_$GV/'MN[CM3XV:+!5B*F-K')RC8^AS
M4<EI(OW2&%?6),^;9(E\R8W ,/R-2Q7T;G).T^]465DX(8'WZT@QT]:'(5C7
M5MV",&EX&,UF1%D.58BK4=XX'S*& ].#5(DM $\#&#0;6.4Y*\_D:;#<(^02
M5)]:L(H( !SFJ2$V0/I9."C$_6KFE:2\*&9T))X!ZXJ2UB$DJKR-YP*VY"MK
M:\  @8 JTB+G/W]P9'$:DA5//N:2WB((/6M$623G+*"3W'!J:#1 [91L@]C6
MT8&3F1VT3$@ 'BK]IIKSD#&15BRTIXP-R'\LBMW2--+,"0<5HM""C::,6(&T
MY-;=CX<!4$@8%:NG:3N8 +DFN@L/#;R+POZ5+J)!&#9R!T(1\[?TJ*72"RG(
MP*[Z3P?(4W;2?PK/OO#;Q<E",4*K<3I,X*YTP)D!22*_HZ_8+/PJ'[$?PC%S
M_P *^-VO@_2A<^;]C\SSA:1>9OSSOW[MV><YSS7\\^HZ*RD\$5BWUG)&A 9U
M [ X%>=FN6?7H1AS\MG?O^J.[+<P^IRE+DYKZ?UN?U4:?\,?!.KV,5U:>'?"
MUU;3J'CEAL('20>H8+@CZ5+_ ,*@\(9Y\+>&QC_J&P__ !->6?\ !,,$?\$_
M/A&#R1X<MO\ T&OQ]_X..?$NJ:3_ ,%$98K/4;^TB/AVQ.R&X=%SF3G -? X
M#+98K%RPO/:U]=]G;:Y]KC<PCA\-'$.%[VT]?D?NM_PJ3PD>/^$8\.'_ +AT
M/_Q-<3\2_P!A+X,_&+39;7Q%\,/ ^HK*,&7^QX(IQ[B1%#@_0U_+3:?$7Q%9
M74<L>NZRCHP(*WD@(_6OKC]@K_@L;\5_V0_B/I0U?Q-K'C#P)+,D>IZ1J=P;
MHK"3AI()'R\;J"2 #M.,$=QZ];AC$TH\]&K=KU7ZL\NEQ#0J/EJT[)^C_0^D
MO^"K'_! 6V^#'@75?B/\%FO[O2-(C:ZU7PW<2&>:VA4$O+;/C<RJ!DHV6QD@
MG&*_*%=1C?@DJ2>0:_KQT#7=.\>^$[+4K*2*]TK6;5+B!\92>&1 P/N"I'YU
M_+Y_P52_9XMOV6OV]OB/X1L(?L^E0ZD;^PCQ@1V]PHG11[*'VCZ5V\.9K5K\
MV'KN[6J?6WF<F?9;3H\M>BK)Z-'C(E#X((.?>G%4<@%0<5ST=PZ?=8KBKL&K
MR*?F(<5]2F?-M%]M/C?)&4)_*F-IDB#Y2''Y4D6K1OU)4]*M13JXRI!QZ4R&
MCJ_V:/C7=?LT?M!>#_'UOI\>I3^$-5@U-+25BB7!C8-L+#D ^M?KG^RQ_P '
M(FK_ +1G[1G@SP++\+=.TN+Q7JL.G-=KK#R-;B1L;PIC&<>F:_&96R.<?2O<
MO^"9MM&?^"@?PA;: P\36AX_WZ\S-,NH5Z<JE6-VD[;^IZ678^M1FJ=.5DVK
M[']('[69S^RO\3./^94U3_TCEK^45&Y )'-?U=_M9J6_97^)@&,GPIJG_I'+
M7\H+P2Q'!4D#N.17B\'_ ,.KZK]3U^*?CI^C_0MHX7 /:IA*% SC K/60EN2
M1_.I!+M YS^-?8GR1H)=;3P2*E6X)QDYQ68LO&<GFI%NL=\@4TQ-%_SBY&22
M*<&P!ZU06\().<4Y;EB1DDU29+1H+<E<#/([U*M^XXW'%9GG$\DD5(LI!'.2
M:8C1-\[D;G)'N:?'<'! 8@'T-9Z3'./6I(YCN XXH V;;7;NT8-'=SH!QPYQ
M6I9_$/5K7I<F0<??&<5S43%\=>:L1H>Y)JT9M'9V/Q>O8B!-!#+GN,J:UK'X
MQVLQ'GVTT8/<$$5YT5."22!3@^!GBJ38FCUVQ^)VDW( %R8BW'[Q2*VK+Q':
M7N3%=0N3Z..:\+\P..,FE1F4D@LK>QQ5*3):/H.*[XR.?ZU/'.2P )&*\&TW
MQ%>Z<1Y%W/$ <C#G%=!8?%/5;=EW3K(!V=0<_C5J1#B>Q1D8)R2*G#@8  YK
MS+3_ (SRJH\^UC8'J48J?ZUJV7QGTZ9E69)XO4X# ?E3NB6CO$E .><GKFK"
M/NXSZ5RVG?$/2K\!4OH06Z!SL_G6U;:M#.,QRQN/]E@:M,ELV(G53G/&*L)/
MCIR!63%>C. <FK45P.<YJKDFBEP2WH33L"3AL$$<YJK'<+D9X-3"[!&3C(]:
M!2(;O0[.[W>;:P.3P3L )JA<?#K3)P"L<D)'38U:8NN_)^E3K."..E-$W.9F
M^%$;DF"\9?\ ?7C]*S[SX9:E;D[!#,#_ '6P?R-=U',3DYX-2+(3@$Y)IJ(F
MSRN]\,7]EDS6DZ '^[D?I6?-9[F *A67L00?I7M><C:2<"H;C2;2_P B>"&4
M'U4'-'*!XQ]C(!P3D>M+%;.2>0#7K%U\.=(O%W"!H21@E&('Y5F77P?BP3;W
MCJ1V= ?Y4TA7//C:D<L@;/X41V[Q$ !ER>,'FNPOOA;J5OEHQ#/CIL;!_6LR
M[\,7^G@F6UG11U(4D?F*9+D8\5W<0D 32 Y[G_&K":S>*20R.!QRN2:D-KG
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M1%MW$X()H9#MP#G/I4K8 XS@"F*F[)R?K0 SROF)X!_.E\OG)&#4F .#SD4
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M &<@=.M#0CIV[5*7XP >::Q)((H CVCUXI&'&1R33Q&7;&,BGK;@MCI_2@"
M1$G  Q2B(Y .2:LI!L;CG_/6I$MV8D(C$MZ#- %(6AY)YQ3UMU7&0 16G#H=
MU*HQ"X'OQ_.K$?A.:3!=XT&/7- &+Y><D9R:5(B>G05OIX6C3 >5R1Z "IX]
M&MX>0A;'J<T <U]GY SFGIILL@PD3MGVKI1!'&0515'L*:Q.2!F@#!70YVQE
M53ZFI%T!NKR ?05K,IQQU-,=0!R0!0!GC184Y)9B/>G+8Q1CB-"?SJQ)<Q1]
M70CVYJ"34H$X#,V*  08484*#[8IIAV\$C\*@GUM%)PI('O5237FY*J!G\:
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MG]ONOM5VMLD<>\(.6ZDLPX%?2 _X-M_VH_\ H7O#'_@\BK[ _P"")G[*E_\
M\$__ /@J=\:_AQXAOHFCT_P]'+I=Y.ZQ_P!I6CW$;Q2KD]=IPP'1@P[5^OEO
M=Q7D*RPR)+&W1D8,I_$5V9EGU:E6Y:-G%I-:=UZG-@,FI5*7-5NI7:?R/Y>/
MVL/^",GQV_8N^#UUX[\<:#I,'ANQGBM[B>SU*.Y:!I7"(64<[2Y"Y]2*^6$E
M:(@JQ%?U9_\ !4WX-_\ "^_^"?'Q7\,K%YL]SH4MU   3YMN1.F/?=&*_EB?
MPA=1M\H#8]\5Z^29A4Q=*4JEKI]#S,VP4<-42ALUU/9/V&/V&?B1^WIXRU?2
M?A]I5GJ-QH%HMY>27-TMM'$C/L4;FX+$YX] :^F[O_@W;_:9E";= \-@+R?^
M)W%7V-_P:K?!1_"O[.?Q%\:7$!CF\0:['ID+$8+1VT(8_ANG/Y&OU7KRLRX@
MKT,3*E22LNZ^_J>C@,DHUL/&I4;NS^4/]J/]DSQK^QG\6)?!GCS3X-/UN.VC
MNPL,ZSQ212 [65UX(R"/J#7&:3;;V&<\U^H?_!TM\*9-+^,_PR\;6\>U-6TJ
MXTF=NQ>&7S$S_P !E/Y5^97A6TGU74+>VB@:2>XD6*-5ZLS' 'YFOK,KQ;Q.
M%A6ENUKZ]3YO,,,J&(E26RV/KO\ 9P_X(W?&S]HSX3:1XU\.Z)I;:#K:.]F]
MUJ*022HKLF[:>0"5.,]:]*M/^"!?Q\C WZ'H"_35XZ_:7]FGX71?!/\ 9^\&
M>$H4"+X?T>VLV  'SK&-YX]6R?QKLKF_ALP#-+'$&X!=@H/YU\76XJQ7/)02
MM?31[?>?5TN',/R)S;O;77K]Q_-KXZ_9JUSX+?$S5?"FO010:QHD_P!GNHXY
M!(H; /##@C!!KZ<_97_X),?$;]H#2[?5$L;?P[H<X#1WVJ%HQ,OK&@!9A[X
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MO_;"_8#^(7[(>I0+XNT41:?>,4MM1MG\ZSN& R5#CHV/X6 /M7SEK6F[%88
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M5*]2GZ/]#=DBCEQN0?RK6^'_ ,(/$'Q<\3P:)X4T75M?U>Y/[JSL+5[B5_\
M@*@G'/6NG_8V_9L\3?MI_'[0_ 'AFW!OM5DW3W3#,5A;KS)._P#LJO;N< <D
M5_1M^RU^Q_\ "S_@FW\#9X=(BT_2;73K7[3K?B&_*K<7>U<O++*?NKQD(#M'
M8=S[&;9U3P24$N:;V7^9Y65Y1/%MR;Y8+=_Y'XB^#?\ @@5^TYXOTR.[/@NR
MTE) &$>H:I!#+]"H8D'V.*P?B[_P1,_:4^#ND37]Y\.[S6;. %GDT6XCOW4
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MRV6E-%&V#U'G%"1WZ5X"XAS#$.^$H:>C?XZ(]MY%@:&F*K:^J7^;/S1\7?\
M!!;]ICPCI[7*>"['5@BY,=AJL$LGT"EE)/TKY<^)7PH\3_!CQ7-H?BW0-6\-
MZO;_ '[34+9[>4#U 8#(]QQ7]#/[*7_!9WX$_M<^,K7PUH?B&[T?Q)?-MM=/
MUBT:U:Z;GY8Y.8V;C[N[)SP#7;?\% ?V$_"?[=GP+U3P[K-C;+KT%O)+H>JB
M,"XTZZ"G80PP3&6P&3."/< A4>)L31K*GCZ?*GY-->>M[H=7A[#UJ3J8*I=K
MS33\O(_F9AEV(."0*MPW@  SC%0>+?#U[X(\5ZGHNHQM!J&CW<ME<QGJDD;E
M&'X$&O:/^"<?[&=]^W=^U%HO@F&:6ST@!K[6;R,9-M9QXWX_VF)"+[L#VK[*
MK7A2INK-^ZE<^0IT)U*BI07O-V.<^!W[.7C_ /:9UYM,\!>$M;\3W,6/--E;
MEHX/>1SA$'/\1%?2-A_P03_:2OM,^TMX7T>!RN1!+K$ E^G!(S^-?MKX?\,?
M#+]@G]GYTM8M(\$>!_"UMYD\S#:H &"[M]Z21CCDY9B<<\"OD7Q#_P ')/P)
MTC7I[2STKQOJEI$^U+R&PCCCE']X*\BOCZ@&OCUQ%F&*DW@:-XKNF_U2^1]8
M\AP.'BEC*MI/S2_1OYGY6_&7_@FO\<_@!:S7'B7X;^(X;& $O>6D'VVV4>I>
M$L /KBO$3F%RK J5X((P0:_I;_8V_P""@'PT_;RT/5+GP#J-Y=RZ*(QJ-I>6
M4EO+:^9NV9W#:P.UOND]*_*?_@Y#^'/A_P"'O[6/A"[T31M.TB?7/#QNK]K.
M!8A=RBYE7S'"@ OM !;J<<UZ&4Y]7K8GZIB:?++^GL_\SAS3)*-'#_6L/4YH
M_P!+='Y_++@CTQ7I'P!_9,^)7[3^HM;^ O!VM^(A$VV6>W@(MH#_ +<K81?Q
M->_?\$>_^"84W[=WQ!N/$'B<7-K\./#4RK>LA*/JT^,BV1@<@ 8+L.@( Y.1
M^SWQ?^.'PF_X)S?!"TGUJ?2O!OAFQ7[-I^GV5O\ O+E@,^7#$@R[=R??+$=:
MUS;B'ZO56&PT>>I^"\M-WY&65Y#[>G]8Q$N2'Y_Y(_'"R_X(-_M'75BLS^'-
M$A9AGRGUB'>/;@D9_&O'_P!H#_@GC\9OV8;&2_\ &'@/6K'2H_O:A @N[1/]
MZ2,LJ]?XL5^ES?\ !RW\+%\3?9D\$>,VTL-C[9O@$F,]?*W?^S5]K_LW_M2?
M#[]M7X7-KW@S5;77M)FS;WEM-$5EMF(YBFB<9!(SU&".02*\RKGV:X:U3%45
MROU7XW=OF>C2R3+,3>&&K/F_KI97^1_,HDIVC!Z5-;ZC-!(&CFD1O4,0:_0W
M_@N%_P $P--_9QOH?BG\/[!;+PEK%T+?5]-A7]UI=R^2LD8_AB?!&WHK8QPP
M _.99\G@@$5]?E^/I8NBJ]+9_@^Q\GC\%4PM9T:NZ_%=SH[/Q]J]@%\N^GP#
M_$=V?SK<T[XUZK;']ZEM,O\ NE37"Q2@DC/('YU(LWS#G@5W)G&T>I:;\=;>
M5E%S9RH#U,; C]:Z#3OBUHU\H#71@8\8D0J*\127MC!IZR @$8&:M2):/H:R
M\16E_AH+J&4?[+@D_A5Z.Y.0<D@\U\XP7+1ME'*GU!P:U=-\8:EIB@07DZ =
M@Y(IJ1#B?04=R<9R1VJQ'.=W4$#J*\1TWXR:M:'$C13CL'3'\JZ#3/CJIP+F
MR(QU,;]/P/\ C6BD)H]5%P 00<XJ9)@PR#G/(XK@]-^,&D7>T//) Q[.A/\
M+-=#IGBRQU(+Y-W!(1_=<9IW$=&)AM/;C@"IE?)ZXQ63%=AV# CGOG(JS%<
M8!)P:"&C25P2 .E/!!.>,?SJB+G)Q@<U,DH.<\#\J<1(EGTFUO4Q-;02D]V0
M9K+O/AII-Z<K \!/>-L#\C6TCDGJ<58M]H)R.:NR!G&W/P7#_-;7A ':5>!^
M59=_\*-5ML[(DN .\;9)_"O44F&W (%#3XR03^%2XBNCQ>[\.7>FG$UK<18R
M3N0X_.JIA5CV!'7WKW,_O@ P# ]<\U3OO"FG:IQ-9V[$]]H!JDB&SQ3[&&)P
M I/2GK9@9XKU2[^#^FW0)A:>W.>S;Q^M9=U\&KJ/+6]S%,O^V"I_K3L#9Y\=
M.&6((P:;]A;<.. .*Z^Z^'6J6).^TD=1T*$.#^54Y-*:U8B170KU# C'M0D)
MLYA]+/=,^GK2KI+(<KO0CTXKHQ9QY& ,]O>EBMT '(R.N>M4D2W<PXGO+=E"
M7$BX[$Y_G5VUUF^B.'$4F.>1S5\P+C(P3].M-5 ,[0,GO3$(OB12<36Y!/'R
MG-1-/H][\LL4:$YX>/'ZBBYA#@$  CBJDEKN4DJ"N*!%K_A#-)OFS$X4D<!)
M/Z&JEW\,-QQ#<D9Z;U_PJ/[$%)(!4]\<417%U:D&.>92.@W$BJ31%RC<_#Z^
MM@2B1RJ/[K<FJ-SHMW;?ZRWE4'G[I/\ *NFC\2W\1^8I+CIN7_"KL7BT' DM
M2%/7:0?T-4D!P>W:,$8(I%X'3 KT'[;I&HD":-%+=GCJ*;P5I=ZH:&3:1_<?
M.:!7.'CNY8>4D=0/?BK::[/$<,$E '5AS6]=?#63)\F<,.V]<50N?!-_ #B(
M2!?XD.<_AUH);*D>MJ^"T; GN#5B.^MY"0)%!/\ >!%4Y].GLF"RPR1D>H(J
M KU/ 'ZTT(UUB5\%2K>X.12^1D],8K'3,3@@E<=QQ4\.HSQODN6'^T,U8&E]
MGV,<_A2-;\9&1C]*A&N8P&B!XZK5F/5H)!RQ0@=",T(F1$("0P.#^%0RZ7!<
M$[XD/X8K00QRXVLK#V.:D, R<=102V84OA6%P?+9TS^(JI/X5FCR8W1\\^AK
MIC;D#IP:;]G)[<BG<#D9M)N(%PT3X'?&:KF([B.<CM7<>4>^14,UC%,"&C1_
MPJDA-G$O!DGBD$)P %! _6NLE\,6\V2A>,GT_P#KU2N/"DB,3'(KCW&*:)9S
MQM"02<X[TAM>"2 2*UKG2;FWW%H6*XZ@;A50Q,,Y!% F5E@&[@$$4CH G?DU
M8$)))(!% B.T<'--*X%0HV"0"/K3#$><C&:O>4.F#BD^S9&<Y_E36]@*?E<=
M"<4AB.1GKFKWV8D<8(]Z:;7G@8/TJC,II&0Q) QBE,0QG&6JT+0\X&/PZTV2
MT;&!U/M0#9390Q& 13A'G@@9JP+8<9..:1XNF!T_6@"OY/ )&33T4*0,=:?Y
M>,DD?2D4$DX!-6D*XR8@<$YQ4,BF0#.#GOBIO+;.3G/7FCRS@#L*87(/+W9+
M G'M2+"%Y()Q5L1Y!R#Z4R3*@C !%!#97<%00 <G\:0/@')/'6I64AB<$@^U
M-,.3SDXH 1)2%&>M*TH;.1U%.2+I@<YIZ0$DG@Y]10!&(E<8(Y/-.2V52" ,
M^]3>6$YX&*8V<CU% FR-HV)QP!_*F&-L G)(_*I0/FZX)-.P1[T$L@9?EQ@@
M#\*:P&X$X-6&R1D X% 17P20"?PH$5_+SSQS0RY' Y%6/(W' ZBD%H0"2<_I
M0!4$1SDD#-+Y6%R2<U;\C.< 8%*+<$#OB@"HL1.2.0*<(@,''-6-HY &32>6
M1C(!SUH A$8X)&<TNPX.2<^OI3W7+8&<TX1]" ,4 ?T"_P#!+M=O_!/[X5CK
M_P 25?\ T8]?EI_P774G_@H1K6,X&D:?_P"B:_4W_@E__P F _"S_L"K_P"C
M'K\N?^"YZAO^"@NL@]/[(L/_ $37Y/PH_P#C(*__ &__ .E(_6>*G_QC]#_M
MS_TEG@?[*/[6_C/]C[XEV?B'PIJ=Q'%'(#?::\K?9-2BS\T<J X.1T;JIP17
M]!GAO5_#O[2/P5L+^2RM]4\,^,M+CG:UNXUDCF@FC!V.O(/#8/N*_FOM;*6^
MNXK>WBDFFF<)''&I9Y&)P% '))/85_1W^R7\-+OX-?LR> O"U^&2]T'0[6TN
M%;!*2+$NY3CCALCCTKJ\1,/1@J.(BK5&VKK=I6_)[>IR>'E>M/VU"6M-).SV
M3?\ FM_0_!S]OS]G"W_97_:T\7^#; NVDV=R+G3M[;G6VF421J3W*AMN>^W/
M>O'!'MQSBOI+_@K#\7-.^-/[=_CC4]*EBN+#3YH]*BGC;<DYMXUB=@>XWJP!
M'! !'!KYQ? /.<FOO\JG5G@Z4J_Q.,;^ME<^ S6%*&,JQH_"I2MZ7=B'RAR2
M>32,IYSR!4I4''0D]_2FOC@=:[S@(@F>104 Y Z5)M.W@=:3;R.O% #"G!]:
M84!.,$8J;:"<<X-! 4$ $4[ 0B/+#(H"<CN33V8#!&<FOI+_ ()=_L9ZO^UO
M^TSHA-C,WA#PW=QZAKEZR9A5(SO6 $\%Y&4+@= 22,"N;&8JGAJ$L15=HQ5W
M_7GT.G!X2IB:T:%)7E)V_KTZGS_XX\!:U\-/%%UH?B'2=2T+6;';]HL;ZW>W
MN(-R!UW(X!&596&1R&!K*;"+R37TW_P65?'_  4I^)GIYNG_ /IMM:^8TA>=
M]J([D^@SFIP&(=?#4Z\E9SC%_>DRL?AEA\34H1=U&37W-H8S 9R>>M,WG.03
MBM*W\+:A=_<MW4'NQ"_SJ[!\/;C(\ZXBCS_=!8UUV.0Y]OF.,]*83@]P#796
MW@"TC"F6264CK_"#5J+P[8V9)6V0D=,_,?UHL!PB6\MP0(XW<^RDYJY;^%;^
MYZ0,@/=^!7<(J1XPJ#'H,4.V, C'X4@.7M? L^0998T ZA<DU?C\&6Z8:26:
M4CT( K7,4LB$QQR.OL,BHA*6RI& .O:@+%2/1;6V4E(8R<_Q#-3QHL:X557'
MH,4KL01G-,W #)8 _6@ 9LY)R1Z4QGQCKSVI'GB[R( /4U!)J=LA),T8P/7K
M0 ]V!!R#FH79A@"-CC\*BEU^U3[TR''XU6E\468S^]R3Z*: +,C2D<1H#[MG
M^502"<J<O$A]@2:JR>)K<CAV(/\ LU7E\3P<#$A'L* +<T4C9W3L?IQ5:6S7
M.2[L:JR>)8\'"N?RJ"7Q.@P5C8CM\PH N-8QD<LYS^%1-80X.0Q(]35)_$PY
MQ%G_ (%4#>)">D8/_ J +[6<(Y* _G36MXQ_ H/Z5G2^(B>D:@CWJ%_$$@'"
M(#0!JNB#C8@Q[5$[+@X51^%93^()/[L8S43:[(!SM_*@#6:49P %-1M+U&<Y
M]:R6UN1LXVC'MTIG]J3'H1^5 &FTI!QFHFDX&2,BJ'V^9R22 #[4AO''\0_*
M@"^)%] :*SS>/ZBB@#QRQ\2-;<2L'4>I&[]*W='UJQOR D@24]%?@UQ*F(Y!
M+J/IFGH8T)*R[3VR"*_-XS:9^M.-ST"4 D[RW/Y4T)'M&,9/O7+:9XAN+0!#
M*DD?HS<?K6U::NEQ@X"YZD'(K133(<6C0DMXIDVO&D@/8\U0NO"<,AW0[8V]
M"<BKL>YE#+D@]Q3]S#!)Z5>CW1-^QSE]HUS9??B!']Y1D52D\W&%&"?05V1E
M!ZX(/7WJG?>'[>^R<&)S_$AQ^E0X7V&I'(2B8G!+Y[C%>_?\$H]Y_P""E/P1
MR6(_X3"PZ_\ 745XM?>%[JSRT9\Y.OR]?RKW+_@E*DG_  \E^":DD!?%UCD?
M]M17-BDU2G?L_P CHPS_ 'L?5?F?U;5^'G_!UCXCOO!_[4'P3U?3+F6SU'2]
M(N+NUGC;:\,J7:LK@]B& /X5^X8[U^&?_!V@I;X^_",A01_PC]W_ .E(KX7(
M5?&17D_R9]=G#_V67R_,_4;_ ()>_MN6'[?/['GAGQQ#)"-;CB&G:_;H1FVU
M")5$HQU"OD.N?X7%;_\ P4!_9 TC]N7]E#Q7\.M46-)=5M_-TZZ89-E>1G?#
M*/3#@ ^JLP[U^&7_  ;P_M\2?LF?M:IX-UZZ:'P3\37CT^;>2([*_P @6\_H
M 23&Q]'!/W:_HSR& (P>]9YEA98/%7AHMU_7D5@,1'%8>T]7L_Z\S^<3_@W^
M\!ZK\,/^"Q^B>'-;M)M/UC0K?6+&]MY 0T,L=O(K*<^XK^CROSA^)W[),7P-
M_P"#@3X6_$_2K:.WT?XHZ7J=O?E5PJZC#8R!CQWD01M[D,:_1ZJSC$*O4A57
M6*_-W%E=!T83IOI)_DC^<3_@Y@1I/^"I6JJH)9O#^F ?]^C7[5?\$EOV5[7]
MD/\ 8*\ >%UME@U6[L$U;5VVX:6\N%$C[O=053Z(*_)+_@N/X(A^(W_!<KPU
MH,KX761X>LV7;D$2.JG.?8U^_5I;)9VZ11JJ1QJ$50,!0!@ ?A75FE9K!4*2
MZJ_W)6.?+Z2>+K5'T=CP+_@J+^U1=?L:?L+^/_'FFR+'K6GV0MM*+ $+=SNL
M438/7:7W?\!K^5'Q#XCO_%NO7FJZI>7%_J6HS-<7-S.Y>6>1CEF9CR23SFOZ
MX?VM/V1?!?[;'PCE\#^/K2^O?#T]U%>/#:W;VKM)&25RR<XR>E?+0_X-MOV5
MP !X8\2\?]3!<?XU62YGAL)3:J)\S?1=.G4G-,OKXFHG!JR74_)K_@WQ_:3U
M?X$_\%'/"6C6UY.FB_$$MH6HVNXF.8NI>%R.FY9%7!Z@,P[U_2P.E?&WP1_X
M(.?LZ_L]?%KP_P"-_#'A_7[77_#-XE_8RRZU/+&DJ]"5)PP]C7V2.*XLXQM'
M$UE4I)K36YUY7A:N'I.G5?72Q^//_!UA\!U3PY\-/BE8(UO>6T\_AV_FB)5I
M(W7SH,D>A64?\"KV3_@V+^/[_$_]A35/"=[<M/J'@37IH$#ON?[+.BS1GUQO
M,H_"NG_X.4O#46M_\$O]9NW0-+HVNZ;=1G^Z3*8C^DAKX!_X-<?CX? W[9_B
M3P1=3LMIXXT)W@0G -U;.LB_CY1E_*O3I0=?)VNL'I\M?R9Y]2:HYHO[R_/_
M (*/WPUG3(M:TFYLYU#P7<3PR*><JRD$?D:_D5_:!\"W_P %/CUXQ\(S&57\
M.:S=Z=M8D\1RL@_0"OZ\V&1BOYN/^"Z7[/5QX7_X*W>(],L8&5?B!/8:A9HH
M^^]RJ1/@#UE5_P Z.%J_+6G3?57^[_AQ\0T>:E":Z.WW_P##'[+?\$0OA._P
MC_X)F?#.":)H;K7;)M=G# AB;IS(I.?^F93\*^C/#GQ(M?$?Q(\2^&XBAN?#
M4=I)/ALD?:$=U!';A/UI_P )/ UO\+_A5X9\,VJ!+;P[I5KID2CH$AA6,#\E
MKXS_ ."?G[1D?Q1_X*O?M:Z+YXEBMY='2T&> MG%):RX'KN(S[UXLHO$2K5^
MVOWR2_)GJ1DJ$:5'OI]R?^1@?\'*7PAD\>?L(:=X@MHB]SX/\0V]RY 'RPS(
M\+\^FYHZ_)S_ ()8_!^7XW_MY?#/P])&9K=M8CO;H8R/)MP9WS[83'XU^_G_
M  4R^%A^,G[!'Q6T..(37+>';J\MEQDF:!#.@'N6C _&ORO_ .#97X3CQG^U
M1XL\7S0%H?"6B>3&[*"$GN9-H /8[$DKZ7)\;[/*JVNL;V^>WXG@9IA.?,J6
MFDK7^6_X'[AKP !T%?DS_P %W/VD9[[]H[PWX&TZZVVWAC3OM=VJL1_I$['
M..XC53_P.OUBO;R.PM99YF"10H9'8\!0!DG\J_G$_:M^,L_Q^_:H\<^,&D::
M#6-7F>V/7;;JVR(?@BK7G\,8;GQ#JO[*_%Z?E<[>(<1R4%37VG^"_I'[.?\
M!'6TA_X8;T*^0 SZI?WEQ.W=W$S1Y/\ P%%KZ(^)T6IS_#C7DT8D:N^GSBSP
M<'SO+;9CWW8KX-_X(+?M.:?KOPMU7X8WUS'#JVCW+ZEI\;M@W,$F/,5?4HXR
M1Z/[5^AIPU>;FD)4\9/F76_RW1Z&6SC/"PY>UC\9M8NK[3]5N8=1BEBOHI66
M=)E*R*^?F# \YSZU]B?L1_MK?#[X-_ >WT7Q)J\FGZC!=SR-&+:20%6;((*@
MBOH_XP_LG>!/CCOEUW0K9K]QC[;;?N+D?5U^]_P+-?)'[0W_  2.UBPT^YOO
M .LKJH0%ETZ_Q%,WLL@^4G_>"_6O0^N8;%15.LW'^NYP?5*^&DZE)<W]=CG/
M^"L?[<'PW^//[-</AOPSJ\VIZI_:T-T8C:R1JL:)("26 '5@,>]?DYXKMD\Q
MV0+CDX->O_'#2-8\ >*;W1=>TZ\TK5;%MD]K<QE)(S].XQR".#7CNOR"7<23
M@_C7VV48.&'HJ%-W6_WGR.:8N=>JYS5GL?T-?\$W?^3$?A6, ?\ %/6__H-<
M1^UQ_P $@?@]^VQ\6&\9^-X/$,NM-:1V1-GJ)@B\N/.WY=IY^8\UV_\ P3>&
M/V$/A6!@X\/6_P#Z#7YV_P#!;'_@HI\:?V8_VRY/#/@+QQ?>']%&BVMU]FBM
MH)%$C[]S9="><#O7PN#P^(K9A4AA9\LKRUVTOY'V6*KT*6!A+$1YHVCIYV/I
MG0/^#=O]F?1;I99M \2:FJG)CNM:EV-['9M/ZU].? S]ESX8?L?^%+FV\$>%
MO#_@[3M@:[GA0(\H7^*69R6;'JS'%?$G_!![_@I]XG_:LE\3> /B;KG]L^,;
M _VII5])''$]Y:G"R180 %HVPW3)5S_=KUS_ (+@_LL>(/VE?V+]3N?"NHZO
M!K?@[=JHL+2YDCBU:W"_OH712!(0@WKD'E,#[U3C(8KZTL'C:KW6MVUKLQX6
M>&^K/%82FMGI9)^A\Q?\%I?^"WV@6'@76/A)\(-9BU?5M7B>SUSQ!92A[:S@
M8%9(()%/SR,."Z\*"<$D\?BTT$+,23G/?-2:BW^FOD8QQ^E0PH;B=(U(+.P4
M?7-??9?E]+!TO9T_F^K/B\=CJN*J<]3Y+L?T0_\ !OI^RA:_L]?L&Z5XCGM1
M%K_Q(D.L7<C+AQ;AF2V3GML&_P#[:&OA7_@Y1_;"U#XE_M+V7PDT^^>/PUX&
MMHKF^MT?"W.HRJ6W,.XCB9 ,]"S^M?M3\"/!,/PW^"GA'P_;Q+##HNCVMDJ
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M .9_1!^PO^SE8?LG_LI^#?!5G%'%+IFGI)?N!@SW<@WS.3WRY(^@'I7X-_\
M!6?]K_4?VN/VR_%%\;N23PYX;NI-&T2WWYCB@B;:T@'3,CAG)]"!V%?T<:K:
MS7.EW,5LZ0SR1,D3L,JC$$ GV!K\;[S_ (-B?'U]>S3R?%'PHTDSL[$Z?<$D
MDY)ZU\=PYCL-3Q%3$XR5I/:]^NY]7G^"Q%2A3P^%C>*WVZ6L?F"LIP#GI7UO
M_P $7/VJM0_9K_;A\,VQNWC\/^-IUT358"V(Y/,R(9".F4E*D'T+#O7T*O\
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M0!&8@.<BAE&,8YI^,GT I6&!S@F@",(%_&FE.Y)XJ7:" 3P*1D![@&@#]_\
M_@F"<_L!?"TXQG1E_P#1CU\C?\%.?V/_ (:?&;]K>_UOQ1\=/"G@+5)[&TBD
MTF_A#3Q(L>%<G>O##D<5]=?\$PAC]@3X6CK_ ,29?_1CU^7/_!=#_E('K(_Z
MA&G_ /HFOQWAZC4JY[7C2J.#]_5)/[2TU31^Q<05J=/(J$JM-37N:-M?9\FF
M?9W[ O\ P3:^!7PMU%/&?A[Q98_&KQ'I!\VVDM+VTE@LI!T9(5D*K(,C!E<X
M."-IQ7'_ /!5#_@H-\9_A_X5O_#NA?#3Q1X!T'4%-M-XHO%6=Y$88*1O SPP
ML1D9+EL=,=:_+_X7?%7Q)\%_&EGXA\*ZQ?Z'K%BX>*XM92C?[K=F4]"IR"."
M*_>G]AS]HS3OV\OV2M-U[6=-L+BXODDTS7M.EA$ELTZ?*XV-D%'4JX!S@/CM
M7H9[@:V6XF&8XS_:87M[VCB^FB]VWRM?H>?D6.HYEAIY?@_]GG:_NZJ2VW?O
M7^=[=3^?5B78LQ+,Q)))R:^I_P#@FG_P3.U;]N7Q1/JFJ3W.B> =&F$=]?QK
MB:]EQG[/!D8W8QN8Y"@C@D@5J_\ !7K]A"Q_8^^-]AJ'A>!XO!WC-9)[*WY(
ML+A6_>VZ]RF&1E[X8C^$$_KO^QW\#K']G']F?P?X1LHHT.FZ;$UTR*!Y]RZA
MYI#ZYD+=><8KV>(N*E2RVGB,$_>J[/LEO\T]#Q^'N%75S*I0QJTI;KNWM\GO
M^!^>G[6'[6OPA_X)V>-KGX:_"7X1>"==UO1E2/5]6URW^VJDI 8Q$D^9(X!Y
M)=0I. .,#+_9G_;R^%?[:OC[3OAW\9?@W\/],_X2&<6FFZOHEF;-;>=^$1CG
MS(]S8 =7QD@$8R:^(_VA+O4?&_[07C?494N;FXOM>O97=@26S._7\*R/".AZ
MMX?\0V&J0>5;SZ=<1W41=N0Z,&'3W%>E2X;P\L*N9R]JU?GYI<W-;>]^_3L>
M;5XDKQQ3Y5'V2=N3ECR\M]K6[=3Z?_X*??\ !+&]_8KNX_%/AF>[UGX>ZC-Y
M/F3#=<:/*Q^6.4@ ,C9PK]R,'!P6X'_@F?\ L2?\-Q?M!C1;ZXFL_"^A6_\
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M#X+_ /!+']GN'QK\1-*M?B%XSN9$M[2"\(^S2W14DQPQM\H10"Q=U9L+D8)
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MI<T7D26IE(VI'*JHFTN<*"-W) /'([+_ (*L_P#!-#PG\8?@3XA\9^$='MM
M\<>&+.74E;381"FKQ1(7DADC489RH)1@-VX $X-?CK^R9?D?M5_#)5!.?%FE
MCU_Y?(J_I&^,(!^$GBD$ @Z1=_\ HEZGB+#+)LPHUL W'FW5V[V?6^]^I7#N
M)EG.7UJ..2ERZ)V2M==+=NA_,3)JKXRTLASU^8U7GU@ 8+LQSZUCR7!/<G%1
MM)P,G-?K9^1FK+JP X;(JM)J9R1N//%4'EZCFF,_) /% %U[[<,$Y Z<U&U^
M%&3SGI5)Y@,@'K4<DISUSG\A0!=.H[6R#_A31J.23SGZU1,HX YIAEY.3P*
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M/V0=5^&OAGP3XETJ]UB]M9Y+O49H?+ACAE$AP$))8E0.P&2:^$/^"?/QS?\
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M$=PWCJZT3=MP=MFH&/IF4U^BZ\@\@YKQK]BGX4+\(?!_C>U6 0#5_'>NZL%
MP"LUXY4_]\!?RKP*&(Y<-4I_S./X7/8JT>;$4ZG\M_QL<W_P5;^/X_9Q_80\
M>ZY%/Y&HW]E_8]@0<,9[H^4"ONJL[_\  #7\]>A^(!&JAP#[CK7Z7_\ !SG^
MT-]G7X=_#.SG ,AFU[44![#$4 /YS'\J_*;2M0(P"< >]?=\,83DP?M'O-W^
M6R/C^(,3SXKD7V5;Y[L]K^&7Q4U'X?>*;#7-"U&XTO5]-E$UM=0/LEB8=P?I
MP1T(XK]./V6?^"\=I<6%MIOQ2T>5)T 0ZQI:!A)_M20<8/NA(]A5[_@G/_P2
MK^"7QM_8N\ ^+O$GA>XU#7==L#<W=Q_:$\8=O-<<*K  8 ' KQ?_ (+0_L7_
M  Y_8X\#^!]3\":3-I$VK7MQ;72O=23K*JQJR_?)P0<]/6N;$8G 8[$?5)P?
M-=J_IYW\C>CA\;@Z'UF$ERV3MZV/T]^#'[5?P]_:"M%D\(^+-(U>5ADVR3!+
ME/K$V''Y5Z%UXK^8K0/BA>^&M3@O=/OKK3KZV</%<6\K121,.A5E((-?NA_P
M2"_:4\3_ +3W[(5IK'BR62]U32[^;3!?N,-?QQA2KL>[#=M)[E<]<UX><9!]
M3A[:$KQO;7?_ ()Z^59U]:G[*<;2M?38A_X*N?L1:;^U)^SYJVLV%E&GC;PI
M:27NG7*+B2ZCC4N]LV/O!@#MST;&.IS^".HZS$P96(1QD8/%?U)ZDD<NG7"S
M &%HV#YZ;<'/Z5_*I\7K^"'XD>(8K; MH]2N5B Z;!*P'Z8KW.#\3.5.=&3N
MHV:^=]/P/'XIP\8SA5CO*]_E8_I#_P"";;!_V#_A41@@^'K?_P!!K\A_^#B8
MC_AX-)G&3X>LOYR5^N'_  3&?S/^"?WPD;.<^'+;_P!!K\@_^#C#44MO^"A\
MB,2N?#MD<]NLE<'#_P#R-JG_ &]^9VYXO^$R'_;OY'R?^S7\?M9_9;^._ACQ
MYH+LNH>';Q;C8#@7$?22)O9T+*?K7]//P9^+&B_'SX2Z#XOT*=+O1?$EDEY;
MMP?E<<HW^TIRI'8@BOY1X'6[F4*=RCDD&OUU_P"#<G]M[][JWP0UZ\X;?JOA
MKS'Z=6N8!D_]M !_MUZG%>7^UHK$07O0W]/^!O\ >>9PUC72JNA/X9;>O_!_
MR/C'_@MS^P))^QM^UWJ%YHUH8O!?CII-7TDHI$=J[.3-; ]MC'(']UUKXRLX
MS:ZG [C"QR*Q_.OZ=/\ @JK^Q#:_MS_LD:WX=AAC/B?1PVJ^'YR!N2[C1L1Y
M[+(I*'Z@]J_FCUK1I]%U6ZL+^WDM[NRE:">*1=KQ.I*LI'8@@BNC(<P^M89*
M3]Z.C_1_UU,<[P/U:O>*]V6J_5'];OA'4XM8\):7>0,&AN[2*:-LY!5D!!_(
MU^3W[9O_  <4?$/]E[]JGQY\/K7X<^%;ZT\)ZO-86]S<7<ZRW$2GY'8#@%E(
M/'K7WG_P2Y^.$'[0W[!?PV\0QSK-=)I,>G7@SEHY[;,#@^YV _1A7Y"_\'(W
M[,-[\)?VV8?'EO:R'0?B+I\4YN IV)>PCRI8R?4HL3CUWGTKY7)<'1EC9X?$
MQONEZI_Y7/I,VQ5:.$C7P[MM?T:.['_!U%\2">?AAX, _P"OVXI3_P '4/Q'
M'_-,/!G_ (&W%?ED".Q_2D?)''(_2OL/["P'_/M?C_F?*_VUC?\ GX_P_P C
M]4$_X.G?B.R@_P#"L/!O_@;<5X5\+?VQ]:_;S_X+)?"[XBZ]I=AHU[>Z]IEH
MMG9LS11)#A1RW))Y)SZU\4Q;BH&"<5[I_P $QY%A_P""@OP?=R$7_A*+/DG
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M<3"[235[]-_T+XDQ>)H4Z=7#RLG=/;Y?J?77_$3O\0<X/PT\(@?]?EQ4B_\
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MN7R1"9E]T(-8>J?#V09(@GA;W0[:UC63)Y&<%+:D=AC]::UD7P.M=+<^#KJ
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MO?/\6_#I4T^4R/F6[LNEO-[X \LGGE 3UK[IK^87]@7]LW6?V$/VB]+\=:5
M^H6L2-::GI_G&-=0M7QNC)P0&!"LIP<%17Z2?\10OAWM\*-:)_["T7_Q%?*9
MKD%?ZPYX:-XO7IH^J/H\NSFBJ*C7E9K3KJ?&?_!R5HIO_P#@IMJSB1%)T#31
M@@Y_U1KZ_P#^#;C_ (*$66J_#0? 7Q9J4<.M:(\EQX8DF? O;5CN>V&?XXV+
M,!G)5CC[M?G1_P %,_VIH?\ @H%^U#J'Q#L]%D\.)<V-M8QV<L_GL!"FW<S
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M'XOZZ_C+59H65-,T[?:6%FQ7&XR!A)*P.2/N+[&N)_X(83-^Q9_P4(^,_P
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MDE8%?^-B269@ ,X R!D_-W_!RG^U3IEQ8^#OA'I]REQ?VUS_ ,)#JRQMN^S
M1R101MCHQ#R-CTVGN*B_:Z_X.5[.?1+S2?@YX7O4O9E,:ZWKJ(JV^1C?% C-
MN8=BY _V37Y2>/\ XA:S\4O&>I>(O$6IWFKZUJ\[7%W>7,A>6>1CDL2?Y= .
M!71E.4XNKC/K^.T>Z7X+T2^\YLUS7"T\+]1P6JZO\?FW]Q^RW_! ;_@HCIWQ
M#^&=O\&?$VHQP^(_#RL= >9\'4+3EC ,]7BYP.I3&/NFOIO_ (*.?\$VO#'_
M  4"\ V\-U<#0_%VC*W]DZRD7F&,'DPRKD;XF.#URIY'<'^<+PYXHOO".N6>
MIZ5?76G:C82K/;W-O(8Y8'4Y#*PY!![BOT[_ &.?^#DK6O VBV>B?&'P]/XH
MBME$:ZYI6R.^<=,RQ,0CGW4KGT)YI9KD.(IXGZ[E[UW:ZWZV[I]4/+,[P]3#
M_4\?MM?I;I?LUT9XK\4?^"'G[0WP\UF6VM_!D'B>R5B([S2KZ&1)1G@[799%
M..Q6MWX,?\$ _CM\3-4C&N:=I?@73F8"2XU&\CGD"]RL4+,2?8E:_1KPM_P7
MK_9K\2:7'<3>+M0TF1TW&"]TR594./NG8&&>W!KD?BO_ ,'$?P/\&6LB^'+7
MQ/XPNP#L%M:I;0$]MSR,& ^BFICF^=S7LXT;/ORO]78MY3DT7[25:Z[<R_17
M/,?VA_\ @@EX)^#O["WBZY\/3ZIXD^)&BVAU:/5)V,8G$"EY((X%;:JN@;&=
MS9 YK\?A<EG*E2K#L1@BON/]L+_@N;\5_P!IW1[W0="6U\ ^&;U&BGATV1GO
M;J-@04DG/(!!P0@7W)KXJEC23(8!BW.>]?0Y'0QM.G)XZ5VW==;>7;Y(^?SF
MM@ZE2*P4;)*SZ7_7YLH27X@^48S[U5>Y<DG))]ZN7.AK)DHY4GL>15672Y[<
M$$97U'(KW'<\<:L[=014D5TP((/2H02!@K2@'!(XQZ]:9+V+J3"=<\!Q^M,$
MO.,DYJ .T; X*FIY<<.,#(YH)'B0],G\:>)&'J<5 C'!!/ IX<@G'&/3BKB!
M.LQ8]3D5()S@<D"JZGH>#C\*=O[DD'T[4S-LM+<#G.<TY;AN#DXJLCYX S^E
M/5CDX(S0!968@=^:G28],D521R ,$FI8Y"%SU-7$3+B3,#D&IH[EN,MS5!)&
MXP"14R2$=1C-,AFA%?N,?,0:N6/B*[LP?+N)4 .<*QK'C?))R>*EC<MQT!H
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MBO1O^"C/_!*72?VRKMO%'AW4(/#GCN*$1O+,K&SU15&$$VT%E8  !U!XX*G
MQ^88?.:>6\08F.+TC4:U[=5\K,_3\1D]3,LAPTL)K*">G?H_G='Y82ZQ\.-*
M.Y;*]5AQA)@Q_E6;??$GP5&Y6&PUJ10./]("@>W2M3XX?\$[/C/\ KNX&N^
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M*U]-\13V(17"-'Z.W(KFS=S.,%R >N#BF@EARX%4F0T>AV'BBQOL+YACE/\
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M!_$:_G6U+4I=0U">ZN)-\]S(TLC]V9CDG\2:_H:_X)6MN_X)Y_"@XQG1%_\
M1CUQ^(&%I4\/"O"-IRE9M=?=?^1U\ 8JI4Q$Z$W>$8W2?35'Y2_\%XE5?^"B
M&N$@ ?V58?\ HFOG']F7]GGQ!^U?\;M%\#>&(E?4M8EPTK_ZJSA49DFD_P!E
M%!/J> .2*^B/^"];'_AXGKH&,#2=/_\ 1-?4O_!MO\!+6S^'/CGXF7$(;4-1
MOQX>LY&7F.&)(YI2OLSR1@D=XL=J]A9I_9_#U/$KXE"*7JU9?Y_(\?\ LO\
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MIUXU_9?_ &Q-9\(Z+X5^&FK:;:6-G.D^LZ$UU=LTD(8AI!*N0"< 8X%?7?\
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MK]8?^"H?B^Z\#_\ !/7XNZC8R-%=)X<N8$< ''F@1']'-?S)#(R#UJN$Z/\
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M_1<-8'_<L1__ "32'_@T3\.'_FN&L_\ A,1__)--9S@/^?J^Z7_R(?V9C?\
MGT_OC_\ )'X>[B. N ?>G*S'J ?QK]OS_P &B'AMB"?C?K/'_4L1_P#R32C_
M (-$_#:G(^-^L?\ A,1__)-']LX#_GZONE_\B+^S,;_SZ?WQ_P#DC\0TCSU.
M*D9B5(R :_;H_P#!HQX=/_-<-8'_ '+$?_R30?\ @T8\.D$'XX:QS_U+$?\
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MXU+'N;(()IXB(X(X'O7[)#_@U(T@?\UOU3_PEH__ )*I1_P:EZ2.GQPU0?\
M<K1__)5-9_EW_/U?=+_Y$3R;'_\ /I_?'_Y(_&HY&..:"<X/(-?LK_Q"E:23
MD_&_4C_W*L?_ ,E4G_$*3I/_ $7#4_\ PEH__DJG_;^7?\_?PE_\B"R3'_\
M/I_?'_Y(_&Q>F>:5<9SP:_9/_B%*TG_HN&IX]/\ A%8\?^E5 _X-2])'_-;M
M1S_V*L?_ ,E4?V_EW_/W\)?_ "(/)<?_ ,^G]\?_ )(_&])3'RA*GVJW!JA
M <9]Q7[#?\0INDC'_%[]2X_ZE6/_ .2J!_P:FZ4/^:WZEQ_U*L?_ ,E4UQ!E
MW_/W\)?_ "(O[$Q__/I_?'_Y(_(-5BNP#\K']139-,89*,& [=Z_8%/^#532
MT8%?CAJ0(_ZE5/\ Y*JPG_!K-8)C_B^&H$CU\*1__)55_K#EO_/W_P EE_\
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MDRS_ )^_^2R_^1#_ %?S'_GU^,?_ )(_(1;IQP9"/UIZZDZ\;V(/J*_78_\
M!J_IW_1<-1_\)6/_ .2J4?\ !K#IX_YK?J!_[E2/_P"2J:XERS_G[_Y++_Y$
MC_5[,?\ GU^,?_DC\C5UB08PJG/J*>-69L;HXR/I7ZW_ /$+'I^,?\+OU#_P
ME(__ )*I?^(66PX_XOAJ''_4J1__ "55?ZRY9_S]_P#)9?\ R(?ZO9C_ ,^O
MQC_\D?DFFIQG&Z%<>U2Q7]MS^Z(!]Z_6G_B%HL, ?\+OO^/^I4C_ /DJE'_!
MK58#&/C??C'_ %*B?_)5'^LN6?\ /W_R67_R(GPYF/\ SZ_\FC_\D?DVK6TG
M(#X]CFGJML0 )9!GVK]9(_\ @URLHB"OQOON/^I43_Y*I3_P:Z69.1\;[T?]
MRFG_ ,E4UQ/EG_/W_P EE_\ (D_ZN9E_SZ_\FC_\D?D^EI"<%;@#'M4JV X"
MW2<_A7ZN#_@UVM!_S7"^_P#"43_Y*I?^(7JU[_'"^/U\)I_\E4_]9\K_ .?O
M_DLO_D0?#F9?\^OQC_\ )'Y3Q64W!6X5O^!UH6.I:K9+MBN&93VW!J_4@?\
M!KU:J<CXX7P_[E1/_DJGC_@V MQT^.-__P"$HG_R737$^6?\_?\ R67_ ,B3
M_JWF7_/K_P FC_\ )'YBV?BG4HB"X+'W -:4'B/5"H<6R2)W('_UZ_2M?^#8
M>)  /CE?C'_4J)_\EU-;_P#!LRUJ28_CMJ*$^GA1/_DJJ7%.5_\ /W_R67_R
M(GPUF7_/K_R:/_R1^;/_  F=[@C^SRI/^]3)O&5O/S=:;NDZ<@'C\:_3F#_@
MV]N[<8'QWO7([MX1C8_^E5.;_@W N7(+?'&9L>O@Z/\ ^2J/]:<K_P"?O_DL
MO_D2?]6<S_Y]?^31_P#DC\L[R[TN[8E+9X"?]D$50F%D5YBQCN%(%?J\?^#<
M29A@_&LD$8Q_PAR<_P#DW43_ /!MN'()^,RD_P#8G)_\ET+BG*_^?O\ Y++_
M .1#_5G,_P#GU_Y-'_Y(_*5+;3)E*LX1CT/2E70;&0X69<]>&&*_5*Z_X-I8
M;PY?XS$'G[O@]%_E=U6_XADH.2/C9<C/IX23_P"2Z:XIRO\ Y^_^2R_^1#_5
MG,_^?7_DT?\ Y(_+D>$8B/DF (Z#(-*G@B25L1R*Y/.<5^HP_P"#9>,=/C?=
M _\ 8II_\EU)'_P;0F+[OQRO!_W*:?\ R737%65?\_?_ "67_P B3_JQFG_/
MK_R:/^9^7:_#N\.%"J,^IP*:W@2]0D")B1QP0:_4Z+_@VWN81A/CO? ?]BFG
M_P EU*/^#<*\W;C\=KQC[^$8S_[=T?ZU97_S]_\ )9?_ "(O]5\S_P"?7_DT
M?_DC\I)_#EU;9W0L#4$FF3Q?>B=0?8U^L4G_  ;@W,H(;XY7!!_ZE!!_[=TA
M_P"#;V8Y'_"[IL'_ *E!/_DNF^*LJ_Y^_P#DLO\ ('PQF?\ SZ_\FC_F?DR]
MNX X;CVQ0D;@$E2:_60_\&V\C$D_&V4D]<^$$Y_\FZ0?\&V9P0?C2S9]?!Z'
M_P!NZ:XKRK_G[_Y++_(E\+YI_P ^O_)H_P"9^3NULDD8_6GC<,# Y_"OU:?_
M (-ID<DGXTR#/IX00?\ MW3#_P &T$9&/^%USC_N4E_^2Z?^MF5?\_?_ "67
M^0O]5LT_Y]?^31_^2/RJW$9Y.*<K$'DD@=*_5 _\&SB$Y_X7=<\_]2DG_P E
MT?\ $,XG_1;KG_PD4_\ DNC_ %LRK_G[_P"2R_R#_5;-/^?7_DT?\S\M1+VP
M<U(L@(4 ]!7ZC_\ $,\O_1;KG/\ V**?_)=.'_!M"!G'QNN>?^I13_Y+I_ZV
M95_S]_\ )9?Y$OA7-/\ GU_Y-'_,_+Z ,V. "?>KULH8@G) K]-D_P"#:HIT
M^-T__A(I_P#)=2)_P;9/'@CXWS\?]2BG_P EU7^MN5?\_?\ R67^0?ZJ9I_S
MZ_\ )H_YGYI),D.<C%5[F^SG#$U^FK_\&VDCDD_'"XY_ZE%/_DNHS_P;5L3D
M_'"Y_P#"13_Y+H_UMRG_ )^_^2R_R)?"F:_\^O\ R:/^9^8IGR<CG-/CE.TX
M.*_3?_B&J8?\UON/_"13_P"2Z</^#:U@,?\ "[[C_P )%/\ Y+IKBW*?^?O_
M )++_(7^J>:_\^O_ ":/^9^944I4D9XJ5)><9.!7Z8#_ (-KW&?^+WW'/_4H
MI_\ )=.'_!MG(/\ FN%QQ_U**?\ R737%V4_\_?_ "67^0/A/-?^?7_DT?\
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M_P FC_F?$C>/'TN4F2P-N0V"T6^$G]:V-)^.)MBH<73J."'</@?4@5]M0?\
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MOP5IL,\T6H72R:C,N=MG9HP,TK'L F0/5BH')%=W_P %</'7A#Q9^VWXDL/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJQK1XGK.A'#8RG&M&.W->Z^:9^H'AKQA^Q5_P2VO9?$7@?5K[X[_ !0M%/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA@1D''%9TL90JSE3I34G'=)IM>II5P5>E"-2K!Q4MFTTGZ'GS X(QS2!&8X
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA5JN-H.3:LG)\[BNC6B5W;JSJS+"8;!0J5Z5)2O-12=VHKD4NZW;LK]$>_\
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MSCO4T^.(Y!8RM/;O)Z&!1T7G\T&("\9P*U+ZR2YR0 KC\C67)$T;,K @BNO
MY91PG-[&_O6W?:]ONO9>21QX[,ZV+456MI?;SM?[[7?FV-:4GH2:CD<YXQ3C
MQ[8I-@;FN\\\C)/?)S29((.<']:F9 /0FHR1N[8S0!(;^2% I.Y1V/(I?,AE
MSO0H3W7G]*AE8$GN341)8G R: +?V6(\B88/M1538WI^E% ']A5%%%?R^?U
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD&@">X<KR,D5$'X/!P*4RCN1@TR0A1E2,&@!?,QW%,:3/ SFF>8.Y%)O'N:
M'[SZT4S>/>B@#^Q:BBBOY?/Z@"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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4K/FO_/\ E]X?ZLY5_P ^(_<?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>bsx-20210112_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bsx="http://www.bostonscientific.com/20210112"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bsx-20210112.xsd" xlink:type="simple"/>
    <context id="ia789858cd2af4b439997b96eb602609a_D20210112-20210112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
        </entity>
        <period>
            <startDate>2021-01-12</startDate>
            <endDate>2021-01-12</endDate>
        </period>
    </context>
    <context id="i159ff2b70866472ea9e751c5e97173e9_D20210112-20210112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-12</startDate>
            <endDate>2021-01-12</endDate>
        </period>
    </context>
    <context id="ia673c7b2a2c947af89749f616a472882_D20210112-20210112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:SeniorNotedue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-12</startDate>
            <endDate>2021-01-12</endDate>
        </period>
    </context>
    <context id="ib525873db31f4efa98674763c0105f8a_D20210112-20210112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000885725</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bsx:A550MCPSSeriesAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-12</startDate>
            <endDate>2021-01-12</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV80L2ZyYWc6MWI4OTE1MWZmYWE0NGQzMDhkNDAzMjZlZWNiODgxNzcvdGFibGU6Y2MyNWU4NzkzZDdmNDc1ODkzMDFlMjc2ODBlZGM1ODQvdGFibGVyYW5nZTpjYzI1ZTg3OTNkN2Y0NzU4OTMwMWUyNzY4MGVkYzU4NF8yLTEtMS0xLTA_9fb420f7-d2a8-4e26-a780-26fed4516f25">0000885725</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV80L2ZyYWc6MWI4OTE1MWZmYWE0NGQzMDhkNDAzMjZlZWNiODgxNzcvdGFibGU6Y2MyNWU4NzkzZDdmNDc1ODkzMDFlMjc2ODBlZGM1ODQvdGFibGVyYW5nZTpjYzI1ZTg3OTNkN2Y0NzU4OTMwMWUyNzY4MGVkYzU4NF81LTEtMS0xLTA_50a7ad46-4686-4bbd-bdac-95b5b0fe2551">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU0_ffff0eea-a667-400c-94be-75e70effbfe4">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8zNjc_e06c245c-3ae0-44b9-8ce0-97929c396545">2021-01-12</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU1_adbca7dc-f47a-4085-9601-6f654fb27444">BOSTON SCIENTIFIC CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6NDEyZmQ3Nzc4NmI3NDk4MmExMjdmODdlMzlmZWZjNWQvdGFibGVyYW5nZTo0MTJmZDc3Nzg2Yjc0OTgyYTEyN2Y4N2UzOWZlZmM1ZF8wLTAtMS0xLTA_672c222c-25b3-4f30-b340-6b254bab75e9">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6NDEyZmQ3Nzc4NmI3NDk4MmExMjdmODdlMzlmZWZjNWQvdGFibGVyYW5nZTo0MTJmZDc3Nzg2Yjc0OTgyYTEyN2Y4N2UzOWZlZmM1ZF8wLTItMS0xLTA_ceaf8c65-d0b6-4fad-a7e4-093bbacb3b51">1-11083</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6NDEyZmQ3Nzc4NmI3NDk4MmExMjdmODdlMzlmZWZjNWQvdGFibGVyYW5nZTo0MTJmZDc3Nzg2Yjc0OTgyYTEyN2Y4N2UzOWZlZmM1ZF8wLTYtMS0xLTA_a38913a8-2e69-44f0-817b-360ed8465c31">04-2695240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDUy_23ac6769-e11d-433e-b41d-40cddbc5d07c">300 Boston Scientific Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU2_089cf7cd-b2ab-40f3-b487-a17b4a8772ae">Marlborough</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU3_47895f6b-adee-462a-a9ad-96bdbbcff6ec">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDUz_96c2e5cf-f174-4a3f-9a69-698a661ca426">01752-1234</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU4_99744e47-afd5-4841-a4ad-cf1db68c115c">508</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDU5_e68a205a-fa24-40d9-a495-ed4946915f8a">683-4000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ODBjOTRmZjY0N2M4NDFiNDhjM2Q2ZDNkMTAyM2JjZTUvdGFibGVyYW5nZTo4MGM5NGZmNjQ3Yzg0MWI0OGMzZDZkM2QxMDIzYmNlNV8wLTAtMS0xLTA_33023a10-c640-4823-99d3-41a933a6fda5">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ODBjOTRmZjY0N2M4NDFiNDhjM2Q2ZDNkMTAyM2JjZTUvdGFibGVyYW5nZTo4MGM5NGZmNjQ3Yzg0MWI0OGMzZDZkM2QxMDIzYmNlNV8yLTAtMS0xLTA_8d40f166-e2b8-4e70-98f3-172a5a8d76bd">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ODBjOTRmZjY0N2M4NDFiNDhjM2Q2ZDNkMTAyM2JjZTUvdGFibGVyYW5nZTo4MGM5NGZmNjQ3Yzg0MWI0OGMzZDZkM2QxMDIzYmNlNV80LTAtMS0xLTA_f7ea084f-2d83-492c-84b5-1b6eaaf1454e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ODBjOTRmZjY0N2M4NDFiNDhjM2Q2ZDNkMTAyM2JjZTUvdGFibGVyYW5nZTo4MGM5NGZmNjQ3Yzg0MWI0OGMzZDZkM2QxMDIzYmNlNV82LTAtMS0xLTA_29dbf24d-d2e2-4f7a-8bff-0f56243f7c73">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i159ff2b70866472ea9e751c5e97173e9_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18xLTAtMS0xLTA_7e877de6-c3b5-45d2-8853-fb30fdfc6bb8">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i159ff2b70866472ea9e751c5e97173e9_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18xLTItMS0xLTA_6657706b-7c01-4993-a1af-8656e989221a">BSX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i159ff2b70866472ea9e751c5e97173e9_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18xLTQtMS0xLTA_233b23e5-22de-48db-847d-2466692c93ca">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia673c7b2a2c947af89749f616a472882_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18yLTAtMS0xLTA_79f24c14-9622-42a9-8094-e8121b2eeddb">0.625% Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia673c7b2a2c947af89749f616a472882_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18yLTItMS0xLTA_3b48d5f4-e2e4-431a-8fd9-8ab6d41446d1">BSX27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia673c7b2a2c947af89749f616a472882_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18yLTQtMS0xLTA_eaa9fed2-c5a4-49f2-a6ad-c0d896eb61bf">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ib525873db31f4efa98674763c0105f8a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18zLTAtMS0xLTEz_af048718-c975-460a-8269-994cd510e25a">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib525873db31f4efa98674763c0105f8a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18zLTItMS0xLTEz_104c2144-d2ee-4c26-8a24-3f40cb19deb1">BSX PR A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib525873db31f4efa98674763c0105f8a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGFibGU6ZjgwNmI3MjMyOTUwNDI2OGIzZDQ2MGZjYjJjYjBkMjMvdGFibGVyYW5nZTpmODA2YjcyMzI5NTA0MjY4YjNkNDYwZmNiMmNiMGQyM18zLTQtMS0xLTEz_0d1236de-2571-4c5b-8712-e4682219b203">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia789858cd2af4b439997b96eb602609a_D20210112-20210112"
      id="id3VybDovL2RvY3MudjEvZG9jOmFjNzI4MmMyZDJiMjRjNGQ4NGQ1YmI2NzkyNmQ5N2VhL3NlYzphYzcyODJjMmQyYjI0YzRkODRkNWJiNjc5MjZkOTdlYV8xL2ZyYWc6NTc1YzkwZWMzMTIzNGFkMmI0YmEwMzNmMWE5MGEzODYvdGV4dHJlZ2lvbjo1NzVjOTBlYzMxMjM0YWQyYjRiYTAzM2YxYTkwYTM4Nl8xNDYw_c0fc06b4-09b8-494b-b7d9-26594b4e4218">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140062673462552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Document<br></strong></div></th>
<th class="th"><div>Jan. 12, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan. 12,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BOSTON SCIENTIFIC CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-11083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2695240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">300 Boston Scientific Way<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752-1234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">683-4000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000885725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member', window );">Senior Note due 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.625% Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember', window );">5.50% MCPS, Series A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BSX PR A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_SeniorNotedue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bsx_A550MCPSSeriesAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MJ[9M=1R$YC:CN;V&9L%>R-B'Z1,KX1U6^F4V7-%J5&GKMDD;%H)G6[DE6M<
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MZ*%K66\=\+H/@Y1DZ>ETSQ07FA:9'M2#PIY49M"8TQ-E1=88O3.O:21\*5=
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M,:@W6]5C6)>E:H\_A?<HN9\;[O\2Q0]02P,$%     @ DS0L4I>*NQS
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M4$L! A0#%     @ DS0L4@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "3-"Q2]R =+.T    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" "3-"Q2F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( ),T+%+O>I?U(04  &H6   8
M      " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" "3-"Q2@ZFE ]0!   R!@  #0              @ %C#0  >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( ),T+%*7BKL<P    !,"   +              "
M 6(/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( ),T+%(WU&O^-@$  "L"   /
M              "  4L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "3
M-"Q2)!Z;HJT   #X 0  &@              @ &N$0  >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "3-"Q299!YDAD!  #/ P  $P
M            @ &3$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 )
+ #X"  #=$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bsx-20210112.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Document</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bostonscientific.com/role/CoverDocument</Role>
      <ShortName>Cover Document</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bsx-20210112.htm">bsx-20210112.htm</File>
    <File>bsx-20210112.xsd</File>
    <File>bsx-20210112_cal.xml</File>
    <File>bsx-20210112_def.xml</File>
    <File>bsx-20210112_lab.xml</File>
    <File>bsx-20210112_pre.xml</File>
    <File>pressrelease-2020prelimina.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bsx-20210112.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 4,
   "dts": {
    "calculationLink": {
     "local": [
      "bsx-20210112_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bsx-20210112_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "bsx-20210112.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bsx-20210112_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bsx-20210112_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bsx-20210112.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "bsx",
   "nsuri": "http://www.bostonscientific.com/20210112",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210112.htm",
      "contextRef": "ia789858cd2af4b439997b96eb602609a_D20210112-20210112",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Document",
     "role": "http://www.bostonscientific.com/role/CoverDocument",
     "shortName": "Cover Document",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bsx-20210112.htm",
      "contextRef": "ia789858cd2af4b439997b96eb602609a_D20210112-20210112",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "bsx_A550MCPSSeriesAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.50% MCPS, Series A",
        "label": "5.50% MCPS, Series A [Member]",
        "terseLabel": "5.50% MCPS, Series A [Member]"
       }
      }
     },
     "localname": "A550MCPSSeriesAMember",
     "nsuri": "http://www.bostonscientific.com/20210112",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "bsx_SeniorNotedue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Note due 2027 [Member]",
        "label": "Senior Note due 2027 [Member]",
        "terseLabel": "Senior Note due 2027 [Member]"
       }
      }
     },
     "localname": "SeniorNotedue2027Member",
     "nsuri": "http://www.bostonscientific.com/20210112",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.bostonscientific.com/role/CoverDocument"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000885725-21-000002-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000885725-21-000002-xbrl.zip
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ME?%&BW/>W@!Y,F#4,V\'?=;12%B^N+HW&[EQ^!L/A+,X<9ISA5B*$X#7TT$
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M/J_B /B?T^"2TUW!\Y-O4$L#!!0    ( ),T+%*A(Y+IB $  .T"   4
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M<;*)&/9'$YACCJN88F%LO=V=ISS(D%NH#EH'.VMLOV?S]&;FZG(:O &;2<"
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M:9_2;)N!-&QG8)F/]#!@.E(70E0FF^;C9CL?UUFV1L.SL(71U8A9F.H.\*X
ME7/0=,P=81=IQT]X29!V>^*DF529[NIK0G@^XZ2*Y^^2(BZ>WNN^/[M+L_)C
MUZU8H<[3^Z3(GLY3J>;2]Z%"D0^X'^@.7(81T.VP!UP5L(CZ0OJ1UR79=?0W
MM=2WA.Q4,.O3UJ#6-#LKY(Z!WDWI77G?GQ:/P.:1D^0AB.R<#"SI>6E5<AU9
MR4VNPM/K]/M,6](<069> /,"N' UT_JIJY=1$HEER.NT8GM8WR1S)J4^F_)S
M_?)3=I4^)',."0ZI)P%!3'=1O@@ 1S@"?J!T-X7=  72+K'L^)AH,EGA_-DQ
M2,W);[#:9H]=0KMFC$$TC9,E[!CJD18:.1B<"G8MCRS_QM!V)=\\M*?,=5=R
MQ<5"S0F!/L>< ]>ENFO '@*""$,7HI%'/$Y@8"7NM>5)2MJTL%]+>!W;_5W"
M.HJW#PUC2+8+ _8RW8YVJ#B?[8TKR>TP=H2X,\!>?I?I(@ZUI>3Z@Z[<6<P7
M\XA(S^=* B%TOXZAY(!"+ 'R91B$+G3=@'35X*[YJ0GQ!:&SAMA=BS7LM0MR
M&"='5J4-'5;";(YZ@#IKC(XFT>: -G6Z9]3 EGCUWT6<**B;8J9[X$B"(/0E
MP*$00(0RTK]*"(E'!;2LFW5>IB;=[:9O]<(Q8)U/B?7$NHY8R^:X+UTCM\>=
MF>K?(M<Q<:@FN6+[Q[3)=>$U-LJU@WO4:A7>9]KJN\?P1G^ZZJ/^Q.?4C;R0
MAWHZ[$FLI\/0!\(E%&C)AP'B1 GN=J[6-0ZF)OHU1F<-TC$H+4IV'8D=BO9
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MOAN%BZ\\D/B@_AV*J6 .V$%/,/KS@/:!G4?4O:>3X,WSYUMH5?"<YOV0LSO
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M1CTP6>KF_@Q5-Q<-X=_'**LD$:^3/)[/F/VR!LW6FOP.$_0;6,EJ;^M<A1#
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M4'"86T:[^(=1GLJ$E_&.M?CLHOATBF^9E4-\\HVGK8A2 <&TUWK0N'H%5A;
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MY4>"#%R_!U!AHQX8PS89<5OXP7C(T'[!E;0/7_O[A))0 '.@+5QZ905::<_
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M"A:G_H]@R6P=) (,-C/V3=R"5T=CXUFX08(T>VL\F[V5LH/LY69X 2)NHEX
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MXC ?>KXS@?\,PY'[Z?\ 4$L! A0#%     @ DS0L4LM.,\.&%@  39T  !
M             ( !     &)S>"TR,#(Q,#$Q,BYH=&U02P$"% ,4    " "3
M-"Q2H6$.JUX#  "P#   $               @ &T%@  8G-X+3(P,C$P,3$R
M+GAS9%!+ 0(4 Q0    ( ),T+%*A(Y+IB $  .T"   4              "
M 4 :  !B<W@M,C R,3 Q,3)?8V%L+GAM;%!+ 0(4 Q0    ( ),T+%+2FI_M
MQ0@  +<^   4              "  ?H;  !B<W@M,C R,3 Q,3)?9&5F+GAM
M;%!+ 0(4 Q0    ( ),T+%+(S]#98@T  /M[   4              "  ?$D
M  !B<W@M,C R,3 Q,3)?;&%B+GAM;%!+ 0(4 Q0    ( ),T+%*[9%;$5 @
M %I!   4              "  84R  !B<W@M,C R,3 Q,3)?<')E+GAM;%!+
M 0(4 Q0    ( ),T+%+AJ@[),BT  "CZ @ >              "  0L[  !P
M<F5S<W)E;&5A<V4M,C R,'!R96QI;6EN82YH=&U02P4&      < !P#0 0
&>6@

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
